| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | FRAS1 VWF MATN2 MATN3 LAMA4 LAMB1 LAMB2 LAMC2 TECTA COLQ ECM1 MFGE8 FBLN2 FBN2 NID1 LTBP1 MUC2 MUC5AC FBN3 | 2.12e-16 | 188 | 149 | 19 | GO:0005201 |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | TRIM72 MYCBP2 RNF19B RNF212 FBXO11 TRIM6 TRIM22 MAP3K1 TRIM10 RFPL4B RNF125 RNF4 UBR5 ZNF451 TRIM56 PRKN MARCHF11 ZNF598 LNX1 MUL1 RNF208 MGRN1 | 3.49e-11 | 512 | 149 | 22 | GO:0019787 |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | TRIM72 MYCBP2 RNF19B RNF212 FBXO11 TRIM6 TRIM22 MAP3K1 TRIM10 RFPL4B RNF125 RNF4 UBR5 ZNF451 TRIM56 PRKN MARCHF11 ZNF598 LNX1 MUL1 RNF208 MGRN1 | 7.28e-11 | 532 | 149 | 22 | GO:0016755 |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | TRIM72 MYCBP2 RNF19B FBXO11 TRIM6 TRIM22 MAP3K1 TRIM10 RFPL4B RNF125 RNF4 UBR5 TRIM56 PRKN MARCHF11 ZNF598 LNX1 MUL1 RNF208 MGRN1 | 3.90e-10 | 473 | 149 | 20 | GO:0004842 |
| GeneOntologyMolecularFunction | acyltransferase activity | TRIM72 USP22 MYCBP2 RNF19B RNF212 HGSNAT FBXO11 TRIM6 TRIM22 MAP3K1 TRIM10 RFPL4B KMT2C RNF125 RNF4 UBR5 ZNF451 TRIM56 PRKN MARCHF11 ZNF598 LNX1 MUL1 RNF208 MGRN1 | 6.19e-10 | 775 | 149 | 25 | GO:0016746 |
| GeneOntologyMolecularFunction | zinc ion binding | TRIM72 USP22 MID2 MYCBP2 RNF19B NSD1 FBXO11 CHD3 TRIM6 SKI TRIM22 MAP3K1 TRIM10 USP44 TRAF4 RNF125 RNF4 UBR5 RASSF1 IGHMBP2 TRIM56 ZFHX2 PRKN MARCHF11 USP3 ZCCHC13 | 2.24e-09 | 891 | 149 | 26 | GO:0008270 |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | TRIM72 MYCBP2 RNF19B TRIM6 TRIM22 TRIM10 RFPL4B RNF125 RNF4 UBR5 ZNF451 TRIM56 PRKN ZNF598 MUL1 RNF208 MGRN1 | 7.65e-09 | 398 | 149 | 17 | GO:0061659 |
| GeneOntologyMolecularFunction | calcium ion binding | DLL4 MATN2 MATN3 PCDH11Y DGKB PKD2L1 DLK1 DLL1 CRB1 SNED1 FBLN2 FBN2 CELSR2 MEGF8 CCBE1 LRP1 LRP2 NID1 LTBP1 FBN3 NOTCH1 NOTCH3 CRB2 | 8.24e-09 | 749 | 149 | 23 | GO:0005509 |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | TRIM72 MYCBP2 RNF19B TRIM6 TRIM22 TRIM10 RFPL4B RNF125 RNF4 UBR5 TRIM56 PRKN ZNF598 MUL1 RNF208 MGRN1 | 1.97e-08 | 372 | 149 | 16 | GO:0061630 |
| GeneOntologyMolecularFunction | transition metal ion binding | TRIM72 USP22 MID2 MYCBP2 RNF19B NSD1 FBXO11 CHD3 TRIM6 SKI TRIM22 MAP3K1 TRIM10 USP44 TRAF4 RNF125 RNF4 UBR5 RASSF1 IGHMBP2 TRIM56 ZFHX2 PRKN MARCHF11 MUC2 USP3 ZCCHC13 | 1.96e-07 | 1189 | 149 | 27 | GO:0046914 |
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme binding | 6.77e-06 | 36 | 149 | 5 | GO:0031624 | |
| GeneOntologyMolecularFunction | structural molecule activity | FRAS1 RAPSN VWF MATN2 MATN3 LAMA4 LAMB1 LAMB2 LAMC2 TECTA COLQ ECM1 MFGE8 FBLN2 FBN2 NID1 LTBP1 MUC2 MUC5AC FBN3 | 1.07e-05 | 891 | 149 | 20 | GO:0005198 |
| GeneOntologyMolecularFunction | ubiquitin-like protein conjugating enzyme binding | 1.47e-05 | 42 | 149 | 5 | GO:0044390 | |
| GeneOntologyMolecularFunction | Notch binding | 4.57e-05 | 27 | 149 | 4 | GO:0005112 | |
| GeneOntologyMolecularFunction | structural constituent of synapse-associated extracellular matrix | 1.65e-04 | 3 | 149 | 2 | GO:0150043 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 3.21e-04 | 44 | 149 | 4 | GO:0140938 | |
| GeneOntologyMolecularFunction | histone H2B deubiquitinase activity | 3.29e-04 | 4 | 149 | 2 | GO:0140936 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 4.23e-04 | 20 | 149 | 3 | GO:0042800 | |
| GeneOntologyMolecularFunction | histone H2A deubiquitinase activity | 8.13e-04 | 6 | 149 | 2 | GO:0140950 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 1.05e-03 | 103 | 149 | 5 | GO:0008276 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | USP22 MID2 NSD1 SKI TRIM22 KMT2C KMT2D RNF4 WTIP ZNF451 PRKN NOTCH1 | 1.06e-03 | 562 | 149 | 12 | GO:0003712 |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 1.15e-03 | 105 | 149 | 5 | GO:0008170 | |
| GeneOntologyMolecularFunction | histone deubiquitinase activity | 1.50e-03 | 8 | 149 | 2 | GO:0140934 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.50e-03 | 8 | 149 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | polysaccharide binding | 1.57e-03 | 31 | 149 | 3 | GO:0030247 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 1.67e-03 | 68 | 149 | 4 | GO:0016279 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.69e-03 | 229 | 149 | 7 | GO:0140993 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 1.77e-03 | 69 | 149 | 4 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 1.96e-03 | 71 | 149 | 4 | GO:0042054 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 2.39e-03 | 10 | 149 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | transcription regulator activator activity | 2.39e-03 | 10 | 149 | 2 | GO:0140537 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 2.43e-03 | 36 | 149 | 3 | GO:0019789 | |
| GeneOntologyMolecularFunction | ATP-dependent diacylglycerol kinase activity | 2.91e-03 | 11 | 149 | 2 | GO:0004143 | |
| GeneOntologyMolecularFunction | hormone activity | 3.45e-03 | 135 | 149 | 5 | GO:0005179 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 3.47e-03 | 83 | 149 | 4 | GO:1990841 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 3.48e-03 | 12 | 149 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity | 4.09e-03 | 13 | 149 | 2 | GO:0005024 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 4.09e-03 | 13 | 149 | 2 | GO:0046975 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | TRIM72 USP22 MID2 MYCBP2 RNF19B RNF212 FBXO11 TRIM6 TRIM22 MAP3K1 TRIM10 RFPL4B USP44 RNF125 RNF4 MEGF8 UBR5 RASSF1 ZNF451 TRIM56 SOCS4 USP40 PRKN MARCHF11 ZNF598 LNX1 USP3 MUL1 SPSB3 RNF208 MGRN1 | 4.82e-12 | 1009 | 148 | 31 | GO:0070647 |
| GeneOntologyBiologicalProcess | post-translational protein modification | TRIM72 USP22 MID2 MYCBP2 RNF19B RNF212 FBXO11 TRIM6 TRIM22 MAP3K1 TRIM10 RFPL4B USP44 RNF125 RNF4 MEGF8 UBR5 RASSF1 ZNF451 TRIM56 SOCS4 USP40 PRKN MARCHF11 ZNF598 LNX1 USP3 MUL1 SPSB3 RNF208 MGRN1 | 2.36e-11 | 1074 | 148 | 31 | GO:0043687 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation | TRIM72 MID2 MYCBP2 RNF19B RNF212 FBXO11 TRIM6 TRIM22 MAP3K1 TRIM10 RFPL4B USP44 RNF125 RNF4 MEGF8 UBR5 RASSF1 ZNF451 TRIM56 SOCS4 PRKN MARCHF11 ZNF598 LNX1 MUL1 SPSB3 RNF208 MGRN1 | 3.84e-11 | 893 | 148 | 28 | GO:0032446 |
| GeneOntologyBiologicalProcess | protein ubiquitination | TRIM72 MID2 MYCBP2 RNF19B FBXO11 TRIM6 TRIM22 MAP3K1 TRIM10 RFPL4B USP44 RNF125 RNF4 MEGF8 UBR5 RASSF1 TRIM56 SOCS4 PRKN MARCHF11 ZNF598 LNX1 MUL1 SPSB3 RNF208 MGRN1 | 1.31e-10 | 811 | 148 | 26 | GO:0016567 |
| GeneOntologyBiologicalProcess | protein polyubiquitination | MYCBP2 RNF19B TRIM6 TRIM22 MAP3K1 RNF125 RNF4 UBR5 TRIM56 PRKN ZNF598 MUL1 MGRN1 | 1.73e-07 | 289 | 148 | 13 | GO:0000209 |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | CHRDL2 KCP CAV3 ACVRL1 SKI DLL1 FBN2 CCBE1 ZNF451 LRP1 LRP2 BAMBI LTBP1 NOTCH1 CRB2 | 2.92e-07 | 412 | 148 | 15 | GO:0090287 |
| GeneOntologyBiologicalProcess | artery morphogenesis | 3.25e-07 | 92 | 148 | 8 | GO:0048844 | |
| GeneOntologyBiologicalProcess | artery development | 5.05e-07 | 133 | 148 | 9 | GO:0060840 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | CHRDL2 KCP CAV3 ACVRL1 SKI MAP3K1 FBN2 MEGF8 ZNF451 LRP1 LRP2 BAMBI LTBP1 NOTCH1 CRB2 | 7.74e-07 | 445 | 148 | 15 | GO:0141091 |
| GeneOntologyBiologicalProcess | axon guidance | MYCBP2 MATN2 LAMB1 LAMB2 LAMC2 SEMA3G EDN3 MEGF8 LRP1 LRP2 NOTCH1 NOTCH3 | 1.06e-06 | 285 | 148 | 12 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | MYCBP2 MATN2 LAMB1 LAMB2 LAMC2 SEMA3G EDN3 MEGF8 LRP1 LRP2 NOTCH1 NOTCH3 | 1.10e-06 | 286 | 148 | 12 | GO:0097485 |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | CHRDL2 KCP CAV3 ACVRL1 SKI FBN2 ZNF451 LRP1 LRP2 BAMBI LTBP1 NOTCH1 CRB2 | 1.37e-06 | 347 | 148 | 13 | GO:0090092 |
| GeneOntologyBiologicalProcess | aorta development | 1.74e-06 | 80 | 148 | 7 | GO:0035904 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | CHRDL2 KCP CAV3 ACVRL1 SKI MAP3K1 FBN2 MEGF8 ZNF451 LRP1 LRP2 BAMBI LTBP1 NOTCH1 CRB2 | 2.08e-06 | 482 | 148 | 15 | GO:0007178 |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | ZFYVE27 CHRDL2 DLL4 KCP CAV3 ACVRL1 SKI DLL1 MAP3K1 FBN2 MEGF8 CCBE1 ZNF451 LRP1 LRP2 BAMBI LTBP1 HAS1 NOTCH1 CRB2 | 2.99e-06 | 850 | 148 | 20 | GO:0071363 |
| GeneOntologyBiologicalProcess | protein catabolic process | TRIM72 USP22 MANBA MYCBP2 RNF19B HGSNAT FBXO11 CAV3 ST14 MAP3K1 USP44 TRAF4 RNF125 RNF4 UBR5 SOCS4 LRP1 LRP2 PRKN ZNF598 LNX1 SPSB3 NOTCH1 | 4.61e-06 | 1115 | 148 | 23 | GO:0030163 |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 4.78e-06 | 131 | 148 | 8 | GO:0030510 | |
| GeneOntologyBiologicalProcess | response to growth factor | ZFYVE27 CHRDL2 DLL4 KCP CAV3 ACVRL1 SKI DLL1 MAP3K1 FBN2 MEGF8 CCBE1 ZNF451 LRP1 LRP2 BAMBI LTBP1 HAS1 NOTCH1 CRB2 | 5.28e-06 | 883 | 148 | 20 | GO:0070848 |
| GeneOntologyBiologicalProcess | positive regulation of viral transcription | 7.13e-06 | 6 | 148 | 3 | GO:0050434 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 1.29e-05 | 197 | 148 | 9 | GO:0030509 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process | TRIM72 USP22 RNF19B FBXO11 CAV3 MAP3K1 USP44 TRAF4 RNF125 RNF4 UBR5 SOCS4 PRKN ZNF598 LNX1 SPSB3 | 1.51e-05 | 640 | 148 | 16 | GO:0006511 |
| GeneOntologyBiologicalProcess | modification-dependent protein catabolic process | TRIM72 USP22 RNF19B FBXO11 CAV3 MAP3K1 USP44 TRAF4 RNF125 RNF4 UBR5 SOCS4 PRKN ZNF598 LNX1 SPSB3 | 1.85e-05 | 651 | 148 | 16 | GO:0019941 |
| GeneOntologyBiologicalProcess | modification-dependent macromolecule catabolic process | TRIM72 USP22 RNF19B FBXO11 CAV3 MAP3K1 USP44 TRAF4 RNF125 RNF4 UBR5 SOCS4 PRKN ZNF598 LNX1 SPSB3 | 2.04e-05 | 656 | 148 | 16 | GO:0043632 |
| GeneOntologyBiologicalProcess | response to BMP | 2.58e-05 | 215 | 148 | 9 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 2.58e-05 | 215 | 148 | 9 | GO:0071773 | |
| GeneOntologyBiologicalProcess | regulation of viral transcription | 2.86e-05 | 25 | 148 | 4 | GO:0046782 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.87e-05 | 218 | 148 | 9 | GO:0090101 | |
| GeneOntologyBiologicalProcess | protein monoubiquitination | 4.24e-05 | 54 | 148 | 5 | GO:0006513 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | ZFYVE27 MYCBP2 MATN2 LAMB1 LAMB2 LAMC2 SEMA3G TECTA ST14 EDN3 MAP3K1 CRB1 CELSR2 MEGF8 WTIP LRP1 LRP2 BAMBI PRKN MUL1 NOTCH1 NOTCH3 | 4.31e-05 | 1194 | 148 | 22 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of viral entry into host cell | 4.63e-05 | 55 | 148 | 5 | GO:0046596 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 5.73e-05 | 11 | 148 | 3 | GO:0110011 | |
| GeneOntologyBiologicalProcess | regulation of viral process | 6.05e-05 | 186 | 148 | 8 | GO:0050792 | |
| GeneOntologyBiologicalProcess | developmental cell growth | 6.53e-05 | 301 | 148 | 10 | GO:0048588 | |
| GeneOntologyBiologicalProcess | modulation by symbiont of entry into host | 8.28e-05 | 62 | 148 | 5 | GO:0052372 | |
| GeneOntologyBiologicalProcess | developmental growth | ZFYVE27 MYCBP2 LAMB2 DLK1 SEMA3G CAV3 SKI DLL1 COLQ ECM1 EDN3 KMT2C KMT2D MEGF8 LRP1 PRKN MUL1 NOTCH1 | 9.57e-05 | 911 | 148 | 18 | GO:0048589 |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 1.24e-04 | 14 | 148 | 3 | GO:2001046 | |
| GeneOntologyBiologicalProcess | neuron projection extension | 1.27e-04 | 207 | 148 | 8 | GO:1990138 | |
| GeneOntologyBiologicalProcess | retina development in camera-type eye | 1.45e-04 | 211 | 148 | 8 | GO:0060041 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 1.75e-04 | 276 | 148 | 9 | GO:0007179 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | VWF LAMB1 LAMB2 ACVRL1 TECTA SNED1 FBLN2 NF1 LRP1 NID1 NOTCH1 | 1.87e-04 | 410 | 148 | 11 | GO:0031589 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial sheet | 1.92e-04 | 74 | 148 | 5 | GO:0002011 | |
| GeneOntologyBiologicalProcess | regulation of biological process involved in symbiotic interaction | 2.05e-04 | 75 | 148 | 5 | GO:0043903 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 2.10e-04 | 41 | 148 | 4 | GO:0035909 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ZFYVE27 MYCBP2 MATN2 LAMB1 LAMB2 LAMC2 SEMA3G EDN3 CELSR2 MEGF8 LRP1 LRP2 PRKN MUL1 NOTCH1 NOTCH3 | 2.15e-04 | 802 | 148 | 16 | GO:0048812 |
| GeneOntologyBiologicalProcess | protein K63-linked ubiquitination | 2.18e-04 | 76 | 148 | 5 | GO:0070534 | |
| GeneOntologyBiologicalProcess | axonogenesis | ZFYVE27 MYCBP2 MATN2 LAMB1 LAMB2 LAMC2 SEMA3G EDN3 MEGF8 LRP1 LRP2 NOTCH1 NOTCH3 | 2.27e-04 | 566 | 148 | 13 | GO:0007409 |
| GeneOntologyBiologicalProcess | positive regulation of BMP signaling pathway | 2.30e-04 | 42 | 148 | 4 | GO:0030513 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | ZFYVE27 MYCBP2 SEMA3G CAV3 DLL1 COLQ MEGF8 LRP1 PRKN MUL1 NOTCH1 | 2.35e-04 | 421 | 148 | 11 | GO:0048638 |
| GeneOntologyBiologicalProcess | proteolysis involved in protein catabolic process | TRIM72 USP22 RNF19B FBXO11 CAV3 MAP3K1 USP44 TRAF4 RNF125 RNF4 UBR5 SOCS4 PRKN ZNF598 LNX1 SPSB3 | 2.47e-04 | 812 | 148 | 16 | GO:0051603 |
| GeneOntologyBiologicalProcess | camera-type eye development | DLL4 LAMB2 ACVRL1 SKI DLL1 MAP3K1 CRB1 KMT2C NF1 NOTCH1 CRB2 | 2.60e-04 | 426 | 148 | 11 | GO:0043010 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ZFYVE27 MYCBP2 MATN2 LAMB1 LAMB2 LAMC2 SEMA3G EDN3 CELSR2 MEGF8 LRP1 LRP2 PRKN MUL1 NOTCH1 NOTCH3 | 2.71e-04 | 819 | 148 | 16 | GO:0120039 |
| GeneOntologyBiologicalProcess | negative regulation of BMP signaling pathway | 2.77e-04 | 80 | 148 | 5 | GO:0030514 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ZFYVE27 MYCBP2 MATN2 LAMB1 LAMB2 LAMC2 SEMA3G EDN3 CELSR2 MEGF8 LRP1 LRP2 PRKN MUL1 NOTCH1 NOTCH3 | 2.98e-04 | 826 | 148 | 16 | GO:0048858 |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 3.04e-04 | 4 | 148 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 3.16e-04 | 299 | 148 | 9 | GO:0060560 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | TRIM72 ZFYVE27 CHRDL2 KCP CAV3 ACVRL1 SKI DLL1 MAP3K1 FBN2 MEGF8 CCBE1 ZNF451 SOCS4 LRP1 LRP2 BAMBI LTBP1 NOTCH1 CRB2 | 3.21e-04 | 1186 | 148 | 20 | GO:0007167 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ZFYVE27 MYCBP2 MATN2 LAMB1 LAMB2 LAMC2 SEMA3G TECTA EDN3 CELSR2 MEGF8 LRP1 LRP2 NOTCH1 NOTCH3 | 3.22e-04 | 748 | 148 | 15 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of type I interferon-mediated signaling pathway | 3.29e-04 | 46 | 148 | 4 | GO:0060338 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 3.29e-04 | 83 | 148 | 5 | GO:0060976 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 3.48e-04 | 84 | 148 | 5 | GO:1903053 | |
| GeneOntologyBiologicalProcess | astrocyte development | 3.57e-04 | 47 | 148 | 4 | GO:0014002 | |
| GeneOntologyBiologicalProcess | venous blood vessel development | 3.77e-04 | 20 | 148 | 3 | GO:0060841 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 4.03e-04 | 377 | 148 | 10 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 4.12e-04 | 378 | 148 | 10 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 4.20e-04 | 379 | 148 | 10 | GO:0045229 | |
| GeneOntologyBiologicalProcess | axon extension | 4.33e-04 | 135 | 148 | 6 | GO:0048675 | |
| GeneOntologyBiologicalProcess | positive regulation of type I interferon-mediated signaling pathway | 4.38e-04 | 21 | 148 | 3 | GO:0060340 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 4.81e-04 | 192 | 148 | 7 | GO:0017015 | |
| GeneOntologyBiologicalProcess | negative regulation of transforming growth factor beta receptor signaling pathway | 4.87e-04 | 138 | 148 | 6 | GO:0030512 | |
| GeneOntologyBiologicalProcess | negative regulation of striated muscle cell differentiation | 4.89e-04 | 51 | 148 | 4 | GO:0051154 | |
| GeneOntologyBiologicalProcess | negative regulation of inner ear receptor cell differentiation | 5.04e-04 | 5 | 148 | 2 | GO:2000981 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 5.04e-04 | 5 | 148 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 5.04e-04 | 5 | 148 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | axon extension involved in regeneration | 5.04e-04 | 5 | 148 | 2 | GO:0048677 | |
| GeneOntologyBiologicalProcess | compartment pattern specification | 5.04e-04 | 5 | 148 | 2 | GO:0007386 | |
| GeneOntologyBiologicalProcess | negative regulation of inner ear auditory receptor cell differentiation | 5.04e-04 | 5 | 148 | 2 | GO:0045608 | |
| GeneOntologyBiologicalProcess | negative regulation of mechanoreceptor differentiation | 5.04e-04 | 5 | 148 | 2 | GO:0045632 | |
| GeneOntologyBiologicalProcess | luteinizing hormone signaling pathway involved in ovarian follicle development | 5.04e-04 | 5 | 148 | 2 | GO:0035471 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 5.27e-04 | 195 | 148 | 7 | GO:1903844 | |
| GeneOntologyBiologicalProcess | positive regulation of Notch signaling pathway | 5.67e-04 | 53 | 148 | 4 | GO:0045747 | |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 5.77e-04 | 23 | 148 | 3 | GO:2001044 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 5.95e-04 | 199 | 148 | 7 | GO:0051147 | |
| GeneOntologyBiologicalProcess | negative regulation of glial cell proliferation | 6.56e-04 | 24 | 148 | 3 | GO:0060253 | |
| GeneOntologyBiologicalProcess | eye development | DLL4 LAMB2 ACVRL1 SKI DLL1 MAP3K1 CRB1 KMT2C NF1 NOTCH1 CRB2 | 7.07e-04 | 480 | 148 | 11 | GO:0001654 |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 7.33e-04 | 336 | 148 | 9 | GO:0071560 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 7.38e-04 | 269 | 148 | 8 | GO:0002064 | |
| GeneOntologyBiologicalProcess | regulation of embryonic development | 7.40e-04 | 99 | 148 | 5 | GO:0045995 | |
| GeneOntologyBiologicalProcess | visual system development | DLL4 LAMB2 ACVRL1 SKI DLL1 MAP3K1 CRB1 KMT2C NF1 NOTCH1 CRB2 | 7.44e-04 | 483 | 148 | 11 | GO:0150063 |
| GeneOntologyBiologicalProcess | axon development | ZFYVE27 MYCBP2 MATN2 LAMB1 LAMB2 LAMC2 SEMA3G EDN3 MEGF8 LRP1 LRP2 NOTCH1 NOTCH3 | 7.46e-04 | 642 | 148 | 13 | GO:0061564 |
| GeneOntologyBiologicalProcess | trabecula morphogenesis | 7.48e-04 | 57 | 148 | 4 | GO:0061383 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell fate commitment | 7.53e-04 | 6 | 148 | 2 | GO:0060120 | |
| GeneOntologyBiologicalProcess | inhibition of neuroepithelial cell differentiation | 7.53e-04 | 6 | 148 | 2 | GO:0002085 | |
| GeneOntologyBiologicalProcess | arterial endothelial cell differentiation | 7.53e-04 | 6 | 148 | 2 | GO:0060842 | |
| GeneOntologyBiologicalProcess | auditory receptor cell fate commitment | 7.53e-04 | 6 | 148 | 2 | GO:0009912 | |
| GeneOntologyBiologicalProcess | sprouting of injured axon | 7.53e-04 | 6 | 148 | 2 | GO:0048682 | |
| GeneOntologyBiologicalProcess | protein K48-linked ubiquitination | 7.74e-04 | 100 | 148 | 5 | GO:0070936 | |
| GeneOntologyBiologicalProcess | viral transcription | 7.99e-04 | 58 | 148 | 4 | GO:0019083 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 8.48e-04 | 343 | 148 | 9 | GO:0071559 | |
| GeneOntologyBiologicalProcess | sensory system development | DLL4 LAMB2 ACVRL1 SKI DLL1 MAP3K1 CRB1 KMT2C NF1 NOTCH1 CRB2 | 8.51e-04 | 491 | 148 | 11 | GO:0048880 |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 8.53e-04 | 59 | 148 | 4 | GO:0085029 | |
| GeneOntologyCellularComponent | extracellular matrix | LAMB4 FRAS1 VWF MATN2 MATN3 LAMA4 LAMB1 LAMB2 LAMC2 MUC5B TECTA GPC6 COLQ ECM1 SNED1 MFGE8 FBLN2 FBN2 FCGBP CCBE1 NID1 LTBP1 MUC2 MUC5AC FBN3 | 7.02e-12 | 656 | 149 | 25 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | LAMB4 FRAS1 VWF MATN2 MATN3 LAMA4 LAMB1 LAMB2 LAMC2 MUC5B TECTA GPC6 COLQ ECM1 SNED1 MFGE8 FBLN2 FBN2 FCGBP CCBE1 NID1 LTBP1 MUC2 MUC5AC FBN3 | 7.50e-12 | 658 | 149 | 25 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | LAMB4 FRAS1 VWF MATN2 MATN3 LAMA4 LAMB1 LAMB2 LAMC2 GPC6 COLQ ECM1 MFGE8 FBLN2 FBN2 NID1 LTBP1 MUC2 | 4.59e-08 | 530 | 149 | 18 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 2.29e-07 | 122 | 149 | 9 | GO:0005604 | |
| GeneOntologyCellularComponent | pituitary gonadotropin complex | 1.94e-05 | 8 | 149 | 3 | GO:0061696 | |
| GeneOntologyCellularComponent | laminin complex | 4.11e-05 | 10 | 149 | 3 | GO:0043256 | |
| GeneOntologyCellularComponent | laminin-2 complex | 5.05e-05 | 2 | 149 | 2 | GO:0005607 | |
| GeneOntologyCellularComponent | microfibril | 9.63e-05 | 13 | 149 | 3 | GO:0001527 | |
| GeneOntologyCellularComponent | mucus layer | 1.51e-04 | 3 | 149 | 2 | GO:0070701 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 2.24e-04 | 17 | 149 | 3 | GO:0098637 | |
| GeneOntologyCellularComponent | matrilin complex | 3.00e-04 | 4 | 149 | 2 | GO:0120216 | |
| GeneOntologyCellularComponent | subapical complex | 4.98e-04 | 5 | 149 | 2 | GO:0035003 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.11e-03 | 109 | 149 | 5 | GO:0005796 | |
| GeneOntologyCellularComponent | neuromuscular junction | 1.25e-03 | 112 | 149 | 5 | GO:0031594 | |
| GeneOntologyCellularComponent | synaptic cleft | 1.66e-03 | 33 | 149 | 3 | GO:0043083 | |
| Domain | EGF | CLEC18A FRAS1 CLEC18B DLL4 MATN2 MATN3 LAMA4 CLEC18C LAMB1 LAMB2 LAMC2 DLK1 TECTA DLL1 CRB1 SNED1 MFGE8 FBLN2 FBN2 FCGBP CELSR2 MEGF8 CCBE1 LRP1 LRP2 NID1 LTBP1 FBN3 NOTCH1 NOTCH3 CRB2 | 2.87e-29 | 235 | 147 | 31 | SM00181 |
| Domain | EGF-like_dom | CLEC18A FRAS1 CLEC18B DLL4 MATN2 MATN3 LAMA4 CLEC18C LAMB1 LAMB2 LAMC2 DLK1 TECTA DLL1 CRB1 SNED1 MFGE8 FBLN2 FBN2 FCGBP CELSR2 MEGF8 CCBE1 LRP1 LRP2 NID1 LTBP1 FBN3 NOTCH1 NOTCH3 CRB2 | 1.79e-28 | 249 | 147 | 31 | IPR000742 |
| Domain | EGF-like_CS | CLEC18A LAMB4 CLEC18B DLL4 MATN2 MATN3 LAMA4 CLEC18C LAMB1 LAMB2 LAMC2 DLK1 DLL1 CRB1 SNED1 MFGE8 FBLN2 FBN2 CELSR2 MEGF8 CCBE1 LRP1 LRP2 NID1 LTBP1 FBN3 NOTCH1 NOTCH3 CRB2 | 3.32e-25 | 261 | 147 | 29 | IPR013032 |
| Domain | Znf_RING/FYVE/PHD | TRIM72 RNF224 PCGF1 RAPSN ZFYVE27 USP22 MID2 MYCBP2 RNF19B RSF1 RNF212 NSD1 CHD3 TRIM6 TRIM22 WDR59 MAP3K1 NSD3 TRIM10 RFPL4B USP44 KMT2C TRAF4 KMT2D RNF125 RNF4 TRIM56 MARCHF11 ZNF598 LNX1 USP3 MUL1 RNF208 KDM4B MGRN1 | 8.75e-25 | 459 | 147 | 35 | IPR013083 |
| Domain | - | TRIM72 RNF224 PCGF1 RAPSN ZFYVE27 USP22 MID2 MYCBP2 RNF19B RSF1 RNF212 NSD1 CHD3 TRIM6 TRIM22 MAP3K1 NSD3 TRIM10 RFPL4B USP44 KMT2C TRAF4 KMT2D RNF125 RNF4 TRIM56 MARCHF11 ZNF598 LNX1 USP3 MUL1 RNF208 KDM4B MGRN1 | 5.65e-24 | 449 | 147 | 34 | 3.30.40.10 |
| Domain | EGF_2 | CLEC18A LAMB4 CLEC18B DLL4 MATN2 MATN3 CLEC18C LAMB1 LAMB2 LAMC2 DLK1 DLL1 CRB1 SNED1 MFGE8 FBLN2 FBN2 CELSR2 MEGF8 CCBE1 LRP1 LRP2 NID1 LTBP1 FBN3 NOTCH1 NOTCH3 CRB2 | 9.74e-24 | 265 | 147 | 28 | PS01186 |
| Domain | EGF_1 | CLEC18A LAMB4 CLEC18B DLL4 LAMA4 CLEC18C LAMB1 LAMB2 LAMC2 DLK1 DLL1 CRB1 SNED1 MFGE8 FBLN2 FBN2 CELSR2 MEGF8 CCBE1 LRP1 LRP2 NID1 LTBP1 FBN3 NOTCH1 NOTCH3 CRB2 | 6.24e-23 | 255 | 147 | 27 | PS00022 |
| Domain | ASX_HYDROXYL | DLL4 MATN2 DLK1 DLL1 CRB1 SNED1 FBLN2 FBN2 CELSR2 MEGF8 CCBE1 LRP1 LRP2 NID1 LTBP1 FBN3 NOTCH1 NOTCH3 CRB2 | 2.46e-21 | 100 | 147 | 19 | PS00010 |
| Domain | EGF_CA | DLL4 MATN2 MATN3 DLK1 DLL1 CRB1 SNED1 FBLN2 FBN2 CELSR2 MEGF8 CCBE1 LRP1 LRP2 NID1 LTBP1 FBN3 NOTCH1 NOTCH3 CRB2 | 4.72e-21 | 122 | 147 | 20 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | DLL4 MATN2 MATN3 DLK1 DLL1 CRB1 SNED1 FBLN2 FBN2 CELSR2 MEGF8 CCBE1 LRP1 LRP2 NID1 LTBP1 FBN3 NOTCH1 NOTCH3 CRB2 | 6.63e-21 | 124 | 147 | 20 | IPR001881 |
| Domain | RING | TRIM72 RNF224 PCGF1 RAPSN MID2 MYCBP2 RNF19B RNF212 NSD1 CHD3 TRIM6 TRIM22 MAP3K1 NSD3 TRIM10 RFPL4B KMT2C TRAF4 KMT2D RNF125 RNF4 TRIM56 ZNF598 LNX1 MUL1 RNF208 MGRN1 | 7.29e-21 | 305 | 147 | 27 | SM00184 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | DLL4 MATN2 DLK1 DLL1 CRB1 SNED1 FBLN2 FBN2 CELSR2 MEGF8 CCBE1 LRP1 LRP2 NID1 LTBP1 FBN3 NOTCH1 NOTCH3 CRB2 | 8.00e-21 | 106 | 147 | 19 | IPR000152 |
| Domain | Znf_RING | TRIM72 RNF224 PCGF1 RAPSN MID2 MYCBP2 RNF19B RNF212 NSD1 CHD3 TRIM6 TRIM22 MAP3K1 NSD3 TRIM10 RFPL4B KMT2C TRAF4 KMT2D RNF125 RNF4 TRIM56 ZNF598 LNX1 MUL1 RNF208 MGRN1 | 4.17e-20 | 326 | 147 | 27 | IPR001841 |
| Domain | EGF_3 | CLEC18A CLEC18B DLL4 MATN2 MATN3 CLEC18C DLK1 DLL1 CRB1 SNED1 MFGE8 FBLN2 FBN2 CELSR2 MEGF8 CCBE1 LRP1 LRP2 NID1 LTBP1 FBN3 NOTCH1 NOTCH3 CRB2 | 4.45e-20 | 235 | 147 | 24 | PS50026 |
| Domain | Growth_fac_rcpt_ | FRAS1 DLL4 MATN2 MATN3 LAMB1 LAMB2 LAMC2 DLL1 CRB1 FBLN2 FBN2 CELSR2 MEGF8 LRP1 LRP2 NID1 LTBP1 FBN3 NOTCH1 NOTCH3 | 7.51e-19 | 156 | 147 | 20 | IPR009030 |
| Domain | ZF_RING_2 | TRIM72 RNF224 PCGF1 RAPSN MID2 MYCBP2 RNF19B RNF212 TRIM6 TRIM22 MAP3K1 TRIM10 RFPL4B KMT2C TRAF4 KMT2D RNF125 RNF4 TRIM56 PRKN ZNF598 LNX1 MUL1 RNF208 MGRN1 | 8.51e-19 | 298 | 147 | 25 | PS50089 |
| Domain | EGF | DLL4 MATN2 MATN3 DLK1 TECTA DLL1 CRB1 SNED1 MFGE8 CELSR2 LRP1 LRP2 NID1 LTBP1 FBN3 NOTCH1 NOTCH3 CRB2 | 6.29e-18 | 126 | 147 | 18 | PF00008 |
| Domain | ZF_RING_1 | TRIM72 RNF224 PCGF1 RAPSN MID2 MYCBP2 RNF19B RNF212 TRIM6 TRIM22 MAP3K1 TRIM10 RFPL4B TRAF4 KMT2D RNF125 RNF4 TRIM56 PRKN ZNF598 LNX1 MUL1 RNF208 MGRN1 | 6.68e-18 | 291 | 147 | 24 | PS00518 |
| Domain | TIL_dom | 1.75e-16 | 14 | 147 | 9 | IPR002919 | |
| Domain | EGF_Ca-bd_CS | DLL1 CRB1 SNED1 FBLN2 FBN2 MEGF8 CCBE1 LRP1 LRP2 NID1 LTBP1 FBN3 NOTCH1 NOTCH3 CRB2 | 1.19e-15 | 97 | 147 | 15 | IPR018097 |
| Domain | EGF_CA | DLL1 CRB1 SNED1 FBLN2 FBN2 MEGF8 CCBE1 LRP1 LRP2 NID1 LTBP1 FBN3 NOTCH1 NOTCH3 CRB2 | 1.63e-15 | 99 | 147 | 15 | PS01187 |
| Domain | VWC_out | 7.82e-15 | 19 | 147 | 9 | SM00215 | |
| Domain | Unchr_dom_Cys-rich | 1.51e-14 | 13 | 147 | 8 | IPR014853 | |
| Domain | C8 | 1.51e-14 | 13 | 147 | 8 | SM00832 | |
| Domain | EGF_CA | MATN2 MATN3 FBLN2 FBN2 MEGF8 CCBE1 LRP1 LRP2 NID1 LTBP1 FBN3 NOTCH1 NOTCH3 | 1.38e-13 | 86 | 147 | 13 | PF07645 |
| Domain | VWF_type-D | 1.48e-13 | 16 | 147 | 8 | IPR001846 | |
| Domain | VWFD | 1.48e-13 | 16 | 147 | 8 | PS51233 | |
| Domain | VWD | 1.48e-13 | 16 | 147 | 8 | SM00216 | |
| Domain | VWD | 1.48e-13 | 16 | 147 | 8 | PF00094 | |
| Domain | VWC | 2.62e-13 | 38 | 147 | 10 | SM00214 | |
| Domain | hEGF | 5.50e-13 | 28 | 147 | 9 | PF12661 | |
| Domain | VWF_dom | 7.94e-13 | 42 | 147 | 10 | IPR001007 | |
| Domain | C8 | 1.24e-12 | 12 | 147 | 7 | PF08742 | |
| Domain | TIL | 1.24e-12 | 12 | 147 | 7 | PF01826 | |
| Domain | Znf_RING_CS | TRIM72 RNF224 PCGF1 MID2 RNF212 TRIM6 TRIM22 TRIM10 RFPL4B TRAF4 RNF125 RNF4 TRIM56 LNX1 RNF208 | 2.96e-12 | 163 | 147 | 15 | IPR017907 |
| Domain | VWFC_2 | 1.22e-11 | 38 | 147 | 9 | PS50184 | |
| Domain | cEGF | 1.68e-11 | 26 | 147 | 8 | PF12662 | |
| Domain | cEGF | 1.68e-11 | 26 | 147 | 8 | IPR026823 | |
| Domain | zf-C3HC4 | TRIM72 PCGF1 RAPSN MID2 TRIM6 TRIM22 TRIM10 TRAF4 RNF125 RNF4 TRIM56 MARCHF11 LNX1 MGRN1 | 2.61e-09 | 223 | 147 | 14 | PF00097 |
| Domain | EGF_LAM_2 | 2.84e-09 | 30 | 147 | 7 | PS50027 | |
| Domain | EGF_LAM_1 | 2.84e-09 | 30 | 147 | 7 | PS01248 | |
| Domain | EGF_Lam | 9.06e-09 | 35 | 147 | 7 | SM00180 | |
| Domain | Laminin_EGF | 9.06e-09 | 35 | 147 | 7 | PF00053 | |
| Domain | VWFC_1 | 1.12e-08 | 36 | 147 | 7 | PS01208 | |
| Domain | Znf_C3HC4_RING-type | TRIM72 PCGF1 MID2 TRIM6 TRIM22 TRIM10 TRAF4 RNF125 RNF4 TRIM56 MARCHF11 LNX1 | 1.16e-08 | 172 | 147 | 12 | IPR018957 |
| Domain | Laminin_EGF | 1.67e-08 | 38 | 147 | 7 | IPR002049 | |
| Domain | VWC | 7.01e-08 | 28 | 147 | 6 | PF00093 | |
| Domain | Glyco_hormone_CN | 7.95e-08 | 15 | 147 | 5 | IPR006208 | |
| Domain | Cys_knot | 7.95e-08 | 15 | 147 | 5 | PF00007 | |
| Domain | CTCK_1 | 2.23e-07 | 18 | 147 | 5 | PS01185 | |
| Domain | Laminin_IV_B | 4.78e-07 | 3 | 147 | 3 | IPR013015 | |
| Domain | LAMININ_IVB | 4.78e-07 | 3 | 147 | 3 | PS51116 | |
| Domain | CT | 6.67e-07 | 22 | 147 | 5 | SM00041 | |
| Domain | ConA-like_dom | TRIM72 MID2 LAMA4 TRIM6 TRIM22 CRB1 TRIM10 RFPL4B CELSR2 SPSB3 CRB2 | 1.31e-06 | 219 | 147 | 11 | IPR013320 |
| Domain | Cys_knot_C | 1.32e-06 | 25 | 147 | 5 | IPR006207 | |
| Domain | CTCK_2 | 1.32e-06 | 25 | 147 | 5 | PS01225 | |
| Domain | PHD | 2.06e-06 | 75 | 147 | 7 | PF00628 | |
| Domain | ZF_BBOX | 3.19e-06 | 80 | 147 | 7 | PS50119 | |
| Domain | Znf_B-box | 3.47e-06 | 81 | 147 | 7 | IPR000315 | |
| Domain | NIDO_dom | 4.72e-06 | 5 | 147 | 3 | IPR003886 | |
| Domain | NIDO | 4.72e-06 | 5 | 147 | 3 | SM00539 | |
| Domain | NIDO | 4.72e-06 | 5 | 147 | 3 | PF06119 | |
| Domain | NIDO | 4.72e-06 | 5 | 147 | 3 | PS51220 | |
| Domain | SPRY | 5.60e-06 | 87 | 147 | 7 | SM00449 | |
| Domain | Post-SET_dom | 6.23e-06 | 16 | 147 | 4 | IPR003616 | |
| Domain | PostSET | 6.23e-06 | 16 | 147 | 4 | SM00508 | |
| Domain | POST_SET | 6.23e-06 | 16 | 147 | 4 | PS50868 | |
| Domain | PHD | 6.52e-06 | 89 | 147 | 7 | SM00249 | |
| Domain | zf-RING_UBOX | 6.53e-06 | 34 | 147 | 5 | PF13445 | |
| Domain | Znf-RING_LisH | 6.53e-06 | 34 | 147 | 5 | IPR027370 | |
| Domain | Znf_PHD | 7.55e-06 | 91 | 147 | 7 | IPR001965 | |
| Domain | SPRY | 9.37e-06 | 94 | 147 | 7 | PF00622 | |
| Domain | SPRY_dom | 9.37e-06 | 94 | 147 | 7 | IPR003877 | |
| Domain | Gonadotropin_bsu_CS | 9.39e-06 | 6 | 147 | 3 | IPR018245 | |
| Domain | WxxW_domain | 9.39e-06 | 6 | 147 | 3 | IPR025155 | |
| Domain | Mucin2_WxxW | 9.39e-06 | 6 | 147 | 3 | PF13330 | |
| Domain | B30.2/SPRY | 1.00e-05 | 95 | 147 | 7 | IPR001870 | |
| Domain | B302_SPRY | 1.00e-05 | 95 | 147 | 7 | PS50188 | |
| Domain | ZF_PHD_2 | 1.00e-05 | 95 | 147 | 7 | PS50016 | |
| Domain | ZF_PHD_1 | 1.08e-05 | 96 | 147 | 7 | PS01359 | |
| Domain | TB | 1.63e-05 | 7 | 147 | 3 | PF00683 | |
| Domain | GLYCO_HORMONE_BETA_1 | 1.63e-05 | 7 | 147 | 3 | PS00261 | |
| Domain | Gonadotropin_bsu | 1.63e-05 | 7 | 147 | 3 | IPR001545 | |
| Domain | GLYCO_HORMONE_BETA_2 | 1.63e-05 | 7 | 147 | 3 | PS00689 | |
| Domain | GHB | 1.63e-05 | 7 | 147 | 3 | SM00068 | |
| Domain | BBOX | 1.71e-05 | 69 | 147 | 6 | SM00336 | |
| Domain | Butyrophylin | 1.86e-05 | 70 | 147 | 6 | IPR003879 | |
| Domain | Znf_FYVE_PHD | 2.16e-05 | 147 | 147 | 8 | IPR011011 | |
| Domain | zf-B_box | 2.19e-05 | 72 | 147 | 6 | PF00643 | |
| Domain | - | 2.60e-05 | 8 | 147 | 3 | 3.90.290.10 | |
| Domain | Znf_PHD-finger | 3.72e-05 | 79 | 147 | 6 | IPR019787 | |
| Domain | TB_dom | 3.88e-05 | 9 | 147 | 3 | IPR017878 | |
| Domain | TB | 3.88e-05 | 9 | 147 | 3 | PS51364 | |
| Domain | EGF_extracell | 1.09e-04 | 60 | 147 | 5 | IPR013111 | |
| Domain | EGF_2 | 1.09e-04 | 60 | 147 | 5 | PF07974 | |
| Domain | C1 | 1.59e-04 | 65 | 147 | 5 | SM00109 | |
| Domain | Znf_UBP | 1.63e-04 | 14 | 147 | 3 | IPR001607 | |
| Domain | zf-UBP | 1.63e-04 | 14 | 147 | 3 | PF02148 | |
| Domain | Ldl_recept_b | 1.63e-04 | 14 | 147 | 3 | PF00058 | |
| Domain | LDLRB | 1.63e-04 | 14 | 147 | 3 | PS51120 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 1.86e-06 | 27 | 110 | 5 | M39545 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 2.38e-06 | 13 | 110 | 4 | M47423 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 3.22e-06 | 30 | 110 | 5 | M27216 | |
| Pathway | PID_NOTCH_PATHWAY | 6.34e-06 | 59 | 110 | 6 | M17 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 1.58e-05 | 7 | 110 | 3 | M27199 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.90e-05 | 21 | 110 | 4 | MM15706 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | VWF MATN3 LAMA4 LAMB1 LAMB2 LAMC2 FBLN2 FBN2 NID1 LTBP1 FBN3 | 2.22e-05 | 300 | 110 | 11 | M610 |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 4.88e-05 | 84 | 110 | 6 | M3228 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 4.88e-05 | 84 | 110 | 6 | M7098 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 7.29e-05 | 11 | 110 | 3 | M158 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 8.23e-05 | 30 | 110 | 4 | M27772 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 9.39e-05 | 31 | 110 | 4 | M592 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 1.03e-04 | 96 | 110 | 6 | M39834 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.62e-04 | 66 | 110 | 5 | M18 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 1.90e-04 | 37 | 110 | 4 | M39506 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.90e-04 | 37 | 110 | 4 | M27134 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 1.96e-04 | 15 | 110 | 3 | M27202 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 2.34e-04 | 39 | 110 | 4 | MM14604 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 2.40e-04 | 16 | 110 | 3 | M47424 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.85e-04 | 41 | 110 | 4 | M27778 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 2.90e-04 | 17 | 110 | 3 | M39389 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.75e-04 | 44 | 110 | 4 | M26969 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 4.09e-04 | 45 | 110 | 4 | M39571 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 4.09e-04 | 19 | 110 | 3 | MM15594 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 4.45e-04 | 46 | 110 | 4 | M239 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 4.45e-04 | 46 | 110 | 4 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 4.83e-04 | 47 | 110 | 4 | M7946 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 5.67e-04 | 49 | 110 | 4 | M618 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 5.94e-04 | 5 | 110 | 2 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 5.94e-04 | 5 | 110 | 2 | MM14733 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 7.56e-04 | 250 | 110 | 8 | M27554 | |
| Pathway | BIOCARTA_NOTCH_PATHWAY | 8.87e-04 | 6 | 110 | 2 | MM1584 | |
| Pathway | BIOCARTA_NOTCH_PATHWAY | 8.87e-04 | 6 | 110 | 2 | M22074 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 8.87e-04 | 6 | 110 | 2 | M27068 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 9.38e-04 | 25 | 110 | 3 | M39713 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 9.38e-04 | 25 | 110 | 3 | M27879 | |
| Pathway | KEGG_FOCAL_ADHESION | 9.39e-04 | 199 | 110 | 7 | M7253 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.15e-03 | 59 | 110 | 4 | M27218 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.22e-03 | 60 | 110 | 4 | MM15636 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 1.24e-03 | 7 | 110 | 2 | M47805 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 1.24e-03 | 7 | 110 | 2 | MM14734 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 1.30e-03 | 61 | 110 | 4 | M39540 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 1.61e-03 | 30 | 110 | 3 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 1.61e-03 | 30 | 110 | 3 | MM15812 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.94e-03 | 32 | 110 | 3 | MM14854 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.95e-03 | 68 | 110 | 4 | M27303 | |
| Pathway | WP_CANCER_PATHWAYS | LAMB4 DLL4 LAMA4 LAMB1 LAMB2 LAMC2 DLL1 TRAF4 RASSF1 NOTCH1 NOTCH3 | 2.01e-03 | 507 | 110 | 11 | M48302 |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 2.10e-03 | 9 | 110 | 2 | M47866 | |
| Pathway | WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS | 2.10e-03 | 9 | 110 | 2 | M39869 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 2.13e-03 | 33 | 110 | 3 | M39503 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 2.17e-03 | 70 | 110 | 4 | M27231 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 2.30e-03 | 118 | 110 | 5 | MM15588 | |
| Pathway | WP_GENE_REGULATORY_NETWORK_MODELLING_SOMITOGENESIS | 2.61e-03 | 10 | 110 | 2 | MM15839 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 2.65e-03 | 74 | 110 | 4 | M616 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 2.85e-03 | 124 | 110 | 5 | M27285 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.93e-03 | 76 | 110 | 4 | M27219 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 3.07e-03 | 77 | 110 | 4 | MM14670 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 3.17e-03 | 11 | 110 | 2 | M47865 | |
| Pathway | WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS | 3.17e-03 | 11 | 110 | 2 | M39647 | |
| Pubmed | FRAS1 VWF MATN2 LAMA4 LAMB1 LAMB2 LAMC2 COLQ ECM1 MFGE8 FBLN2 NID1 LTBP1 MUC2 | 2.68e-14 | 167 | 153 | 14 | 22159717 | |
| Pubmed | VWF MATN2 LAMA4 LAMB1 LAMB2 LAMC2 COLQ ECM1 FBLN2 NID1 LTBP1 MUC2 | 4.40e-12 | 153 | 153 | 12 | 25037231 | |
| Pubmed | 5.51e-10 | 41 | 153 | 7 | 22675208 | ||
| Pubmed | 1.07e-09 | 146 | 153 | 10 | 27068509 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 4.47e-09 | 15 | 153 | 5 | 15895400 | |
| Pubmed | 5.36e-09 | 6 | 153 | 4 | 19110483 | ||
| Pubmed | 6.20e-09 | 175 | 153 | 10 | 28071719 | ||
| Pubmed | 7.98e-09 | 34 | 153 | 6 | 17015435 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 9.15e-09 | 17 | 153 | 5 | 15821257 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 9.49e-09 | 135 | 153 | 9 | 28675934 | |
| Pubmed | 1.25e-08 | 7 | 153 | 4 | 7921537 | ||
| Pubmed | 1.26e-08 | 18 | 153 | 5 | 11311202 | ||
| Pubmed | 1.40e-08 | 64 | 153 | 7 | 22261194 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.49e-08 | 248 | 153 | 11 | 24006456 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FRAS1 PGAP3 MYCBP2 TMC6 NSD1 LAMB2 RALGAPA2 DLL1 CDC42BPB WDR59 ST14 NSD3 KMT2C TRAF4 KMT2D WIZ CELSR2 MEGF8 USP40 BAMBI NOTCH1 | 1.91e-08 | 1105 | 153 | 21 | 35748872 |
| Pubmed | The extracellular-matrix protein matrilin 2 participates in peripheral nerve regeneration. | 4.46e-08 | 9 | 153 | 4 | 19295126 | |
| Pubmed | 4.46e-08 | 9 | 153 | 4 | 16245338 | ||
| Pubmed | 4.46e-08 | 9 | 153 | 4 | 15296947 | ||
| Pubmed | 5.67e-08 | 118 | 153 | 8 | 21078624 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 6.18e-08 | 79 | 153 | 7 | 18757743 | |
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 7.41e-08 | 10 | 153 | 4 | 23665443 | |
| Pubmed | 7.41e-08 | 10 | 153 | 4 | 24015274 | ||
| Pubmed | 7.41e-08 | 10 | 153 | 4 | 9034910 | ||
| Pubmed | Human CLEC18 Gene Cluster Contains C-type Lectins with Differential Glycan-binding Specificity. | 8.35e-08 | 3 | 153 | 3 | 26170455 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 19718741 | ||
| Pubmed | Intrinsic selectivity of Notch 1 for Delta-like 4 over Delta-like 1. | 8.35e-08 | 3 | 153 | 3 | 23839946 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 16336259 | ||
| Pubmed | Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection. | 8.35e-08 | 3 | 153 | 3 | 33603190 | |
| Pubmed | 9.42e-08 | 26 | 153 | 5 | 24742657 | ||
| Pubmed | 1.12e-07 | 86 | 153 | 7 | 35103284 | ||
| Pubmed | Notch signaling prevents mucous metaplasia in mouse conducting airways during postnatal development. | 1.15e-07 | 27 | 153 | 5 | 21791528 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 1.16e-07 | 11 | 153 | 4 | 23472759 | |
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 1.16e-07 | 11 | 153 | 4 | 21524702 | |
| Pubmed | 1.73e-07 | 12 | 153 | 4 | 15465494 | ||
| Pubmed | 1.73e-07 | 12 | 153 | 4 | 9396756 | ||
| Pubmed | 2.50e-07 | 13 | 153 | 4 | 12682087 | ||
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 2.50e-07 | 13 | 153 | 4 | 11578869 | |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 18824585 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 16709836 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 25638393 | ||
| Pubmed | Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast. | 3.33e-07 | 4 | 153 | 3 | 22269464 | |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 22691042 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 23807779 | ||
| Pubmed | Role of mesenchymal nidogen for epithelial morphogenesis in vitro. | 3.33e-07 | 4 | 153 | 3 | 7925005 | |
| Pubmed | Analysis of HeyL expression in wild-type and Notch pathway mutant mouse embryos. | 3.33e-07 | 4 | 153 | 3 | 11044625 | |
| Pubmed | Endothelial basement membrane limits tip cell formation by inducing Dll4/Notch signalling in vivo. | 3.33e-07 | 4 | 153 | 3 | 21979816 | |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 24951930 | ||
| Pubmed | Canonical Notch ligands and Fringes have distinct effects on NOTCH1 and NOTCH2. | 3.33e-07 | 4 | 153 | 3 | 32820046 | |
| Pubmed | No evidence for a functional role of bi-directional Notch signaling during angiogenesis. | 3.33e-07 | 4 | 153 | 3 | 23300864 | |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 17471237 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 14984930 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 3.33e-07 | 4 | 153 | 3 | 29869461 | |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 23162128 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 12676567 | ||
| Pubmed | Changes in laminin isoforms associated with brain tumor invasion and angiogenesis. | 3.33e-07 | 4 | 153 | 3 | 16146715 | |
| Pubmed | 3.48e-07 | 14 | 153 | 4 | 14757642 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | FRAS1 MANBA MYCBP2 MATN2 LAMA4 LAMB1 LAMB2 ECM1 DMXL1 FBN2 NF1 CELSR2 MEGF8 BTD LRP1 NID1 LTBP1 NOTCH1 NOTCH3 MGRN1 | 3.54e-07 | 1201 | 153 | 20 | 35696571 |
| Pubmed | VWF MYCBP2 LAMA4 LAMB2 CHD3 SKI TRAF4 KMT2D FBN2 RNF4 UBR5 ZNF451 LRP1 NID1 | 3.96e-07 | 591 | 153 | 14 | 15231748 | |
| Pubmed | Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. | 4.50e-07 | 35 | 153 | 5 | 21252157 | |
| Pubmed | 4.73e-07 | 15 | 153 | 4 | 12971992 | ||
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 4.73e-07 | 15 | 153 | 4 | 12921739 | |
| Pubmed | 6.00e-07 | 37 | 153 | 5 | 24673559 | ||
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 6.29e-07 | 16 | 153 | 4 | 12617809 | |
| Pubmed | 6.29e-07 | 16 | 153 | 4 | 17273555 | ||
| Pubmed | 6.29e-07 | 16 | 153 | 4 | 17601529 | ||
| Pubmed | 7.43e-07 | 71 | 153 | 6 | 33541421 | ||
| Pubmed | 8.20e-07 | 17 | 153 | 4 | 18694942 | ||
| Pubmed | 8.20e-07 | 17 | 153 | 4 | 39315665 | ||
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 8.29e-07 | 5 | 153 | 3 | 11062147 | |
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 19110448 | ||
| Pubmed | Differential expression of MUC genes in endometrial and cervical tissues and tumors. | 8.29e-07 | 5 | 153 | 3 | 16188033 | |
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 20554499 | ||
| Pubmed | Expression patterns of Notch receptors and their ligands Jagged and Delta in human placenta. | 8.29e-07 | 5 | 153 | 3 | 21726900 | |
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 2468994 | ||
| Pubmed | Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. | 8.29e-07 | 5 | 153 | 3 | 11006133 | |
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 23675950 | ||
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 30181175 | ||
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 11733994 | ||
| Pubmed | A comprehensive framework of E2-RING E3 interactions of the human ubiquitin-proteasome system. | 9.73e-07 | 118 | 153 | 7 | 19690564 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.05e-06 | 18 | 153 | 4 | 18834073 | |
| Pubmed | 1.05e-06 | 18 | 153 | 4 | 18093989 | ||
| Pubmed | 1.05e-06 | 18 | 153 | 4 | 15689374 | ||
| Pubmed | 1.33e-06 | 19 | 153 | 4 | 20335360 | ||
| Pubmed | 1.33e-06 | 19 | 153 | 4 | 16518823 | ||
| Pubmed | 1.65e-06 | 20 | 153 | 4 | 22911573 | ||
| Pubmed | A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development. | 1.65e-06 | 20 | 153 | 4 | 12588999 | |
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 1678389 | ||
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 10958687 | ||
| Pubmed | The beta chorionic gonadotropin-beta luteinizing gene cluster maps to human chromosome 19. | 1.65e-06 | 6 | 153 | 3 | 6204923 | |
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 26555376 | ||
| Pubmed | Effect of basement membrane entactin on epidermal cell attachment and growth. | 1.65e-06 | 6 | 153 | 3 | 3794389 | |
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 9882480 | ||
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 2422163 | ||
| Pubmed | Laminin-nidogen complex. Extraction with chelating agents and structural characterization. | 1.65e-06 | 6 | 153 | 3 | 3109910 | |
| Pubmed | The beta subunit of human chorionic gonadotropin is encoded by multiple genes. | 1.65e-06 | 6 | 153 | 3 | 6194155 | |
| Pubmed | Structural elucidation of full-length nidogen and the laminin-nidogen complex in solution. | 1.65e-06 | 6 | 153 | 3 | 23948589 | |
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 17822320 | ||
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 1371113 | ||
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 2119632 | ||
| Pubmed | Expression of Deltex1 during mouse embryogenesis: comparison with Notch1, 2 and 3 expression. | 1.65e-06 | 6 | 153 | 3 | 11731257 | |
| Interaction | IGFL3 interactions | FRAS1 MANBA MYCBP2 LAMB1 LAMB2 FBN2 UBR5 LRP2 NOTCH1 NOTCH3 MGRN1 | 7.54e-12 | 75 | 148 | 11 | int:IGFL3 |
| Interaction | FBXO2 interactions | FRAS1 DNAJC13 MANBA IL25 LAMA4 LAMB1 LAMB2 LAMC2 ST14 SNED1 FBN2 MEGF8 BTD LRP2 NID1 NOTCH1 NOTCH3 MGRN1 | 1.41e-09 | 411 | 148 | 18 | int:FBXO2 |
| Interaction | NTN5 interactions | 1.71e-08 | 24 | 148 | 6 | int:NTN5 | |
| Interaction | UBE2D2 interactions | RNF224 MID2 MYCBP2 RNF19B MAP3K1 TRIM10 RNF125 RNF4 UBR5 PRKN ZNF598 LNX1 MUL1 MGRN1 | 9.83e-08 | 318 | 148 | 14 | int:UBE2D2 |
| Interaction | UBE2D3 interactions | PCGF1 MID2 MYCBP2 RNF19B MAP3K1 TRIM10 RNF125 RNF4 UBR5 PRKN ZNF598 MUL1 MGRN1 | 1.77e-07 | 283 | 148 | 13 | int:UBE2D3 |
| Interaction | NID2 interactions | 2.29e-07 | 86 | 148 | 8 | int:NID2 | |
| Interaction | UBE2D4 interactions | 2.37e-07 | 119 | 148 | 9 | int:UBE2D4 | |
| Interaction | UBE2D1 interactions | TRIM72 MID2 TRIM22 MAP3K1 TRIM10 TRAF4 RNF125 RNF4 UBR5 PRKN ZNF598 MUL1 MGRN1 | 2.74e-07 | 294 | 148 | 13 | int:UBE2D1 |
| Interaction | ATXN7 interactions | 1.42e-06 | 109 | 148 | 8 | int:ATXN7 | |
| Interaction | MFAP5 interactions | 2.18e-06 | 52 | 148 | 6 | int:MFAP5 | |
| Interaction | HOXA1 interactions | VWF CHRDL2 LAMB2 TRAF4 FBLN2 RNF4 MEGF8 LTBP1 LNX1 NOTCH1 RNF208 INO80B NOTCH3 | 2.34e-06 | 356 | 148 | 13 | int:HOXA1 |
| Interaction | ATRN interactions | 3.05e-06 | 55 | 148 | 6 | int:ATRN | |
| Interaction | ZFP41 interactions | 3.78e-06 | 57 | 148 | 6 | int:ZFP41 | |
| Interaction | FBLN1 interactions | 5.04e-06 | 129 | 148 | 8 | int:FBLN1 | |
| Interaction | PSG8 interactions | 1.21e-05 | 41 | 148 | 5 | int:PSG8 | |
| Interaction | EDN3 interactions | 1.50e-05 | 108 | 148 | 7 | int:EDN3 | |
| Interaction | MANBA interactions | 1.88e-05 | 75 | 148 | 6 | int:MANBA | |
| Interaction | TOP3B interactions | FRAS1 PGAP3 MID2 MYCBP2 TMC6 NSD1 LAMB2 RALGAPA2 DLL1 CDC42BPB WDR59 ST14 NSD3 KMT2C TRAF4 KMT2D WIZ SMG7 CELSR2 MEGF8 TRIM56 USP40 BAMBI PRKN ZNF598 NOTCH1 | 2.41e-05 | 1470 | 148 | 26 | int:TOP3B |
| Interaction | GPHA2 interactions | 3.13e-05 | 25 | 148 | 4 | int:GPHA2 | |
| Interaction | CACNA1A interactions | 3.49e-05 | 123 | 148 | 7 | int:CACNA1A | |
| Interaction | IGHG1 interactions | 3.61e-05 | 169 | 148 | 8 | int:IGHG1 | |
| Interaction | CFC1 interactions | 4.07e-05 | 126 | 148 | 7 | int:CFC1 | |
| Interaction | SIRPD interactions | 4.11e-05 | 86 | 148 | 6 | int:SIRPD | |
| Interaction | PTPRK interactions | 5.01e-05 | 177 | 148 | 8 | int:PTPRK | |
| Interaction | PRG2 interactions | 5.01e-05 | 285 | 148 | 10 | int:PRG2 | |
| Interaction | TRGV3 interactions | 5.17e-05 | 55 | 148 | 5 | int:TRGV3 | |
| Interaction | LTBP1 interactions | 6.01e-05 | 92 | 148 | 6 | int:LTBP1 | |
| Interaction | SESN3 interactions | 6.13e-05 | 11 | 148 | 3 | int:SESN3 | |
| Interaction | NMS interactions | 6.60e-05 | 30 | 148 | 4 | int:NMS | |
| Interaction | NOTCH2 interactions | LAMB2 DLK1 ZNF235 DLL1 ST14 EDN3 FBN2 RNF4 LTBP1 ZNF598 NOTCH1 NOTCH3 | 6.98e-05 | 423 | 148 | 12 | int:NOTCH2 |
| Interaction | PRELP interactions | 8.56e-05 | 32 | 148 | 4 | int:PRELP | |
| Interaction | SLURP1 interactions | 9.49e-05 | 144 | 148 | 7 | int:SLURP1 | |
| Interaction | ZNF408 interactions | 9.91e-05 | 145 | 148 | 7 | int:ZNF408 | |
| Interaction | FBN2 interactions | 1.16e-04 | 65 | 148 | 5 | int:FBN2 | |
| Interaction | TSC22D1 interactions | 1.19e-04 | 104 | 148 | 6 | int:TSC22D1 | |
| Interaction | FBLN2 interactions | 1.24e-04 | 66 | 148 | 5 | int:FBLN2 | |
| Interaction | IGSF5 interactions | 1.33e-04 | 14 | 148 | 3 | int:IGSF5 | |
| Interaction | TAFAZZIN interactions | 1.49e-04 | 207 | 148 | 8 | int:TAFAZZIN | |
| Interaction | LGALS1 interactions | 1.76e-04 | 332 | 148 | 10 | int:LGALS1 | |
| Interaction | KDM1A interactions | DNAJC13 IKZF3 USP22 MYCBP2 E2F4 CHD3 TRAF4 KMT2D WIZ SMG7 ZNF532 UBR5 RASSF1 ZNF451 LRP1 LRP2 ZNF598 NOTCH1 | 1.91e-04 | 941 | 148 | 18 | int:KDM1A |
| Interaction | UBE2L6 interactions | 2.17e-04 | 116 | 148 | 6 | int:UBE2L6 | |
| Interaction | COL6A1 interactions | 2.27e-04 | 117 | 148 | 6 | int:COL6A1 | |
| Interaction | EGFL7 interactions | 2.58e-04 | 77 | 148 | 5 | int:EGFL7 | |
| Cytoband | 3p25 | 2.38e-05 | 17 | 153 | 3 | 3p25 | |
| GeneFamily | Ring finger proteins | TRIM72 RNF224 PCGF1 RAPSN MID2 RNF19B RNF212 TRIM6 TRIM22 TRIM10 RFPL4B TRAF4 RNF125 RNF4 TRIM56 MARCHF11 LNX1 MUL1 RNF208 MGRN1 | 5.88e-16 | 275 | 114 | 20 | 58 |
| GeneFamily | Laminin subunits | 6.98e-09 | 12 | 114 | 5 | 626 | |
| GeneFamily | CD molecules|Mucins | 8.26e-06 | 21 | 114 | 4 | 648 | |
| GeneFamily | PHD finger proteins | 2.23e-05 | 90 | 114 | 6 | 88 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 3.03e-05 | 95 | 114 | 6 | 59 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 6.01e-05 | 34 | 114 | 4 | 487 | |
| GeneFamily | Ubiquitin specific peptidases | 4.28e-04 | 56 | 114 | 4 | 366 | |
| GeneFamily | Zinc fingers HIT-type | 5.81e-04 | 6 | 114 | 2 | 83 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 8.11e-04 | 7 | 114 | 2 | 785 | |
| GeneFamily | PDZ domain containing|Crumbs complex | 1.38e-03 | 9 | 114 | 2 | 1223 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 1.72e-03 | 10 | 114 | 2 | 1178 | |
| GeneFamily | Low density lipoprotein receptors | 2.94e-03 | 13 | 114 | 2 | 634 | |
| GeneFamily | C-type lectin domain family | 3.24e-03 | 47 | 114 | 3 | 494 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | LAMB4 FRAS1 VWF MATN2 MATN3 KCP LAMA4 LAMB1 LAMB2 LAMC2 TECTA COLQ ECM1 SNED1 MFGE8 FNDC7 FBLN2 FBN2 NID1 LTBP1 FBN3 | 9.71e-21 | 196 | 152 | 21 | M3008 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | FRAS1 VWF MATN2 MATN3 KCP LAMA4 LAMB1 LAMB2 LAMC2 TECTA COLQ ECM1 SNED1 MFGE8 FNDC7 FBLN2 FBN2 NID1 LTBP1 | 3.07e-18 | 191 | 152 | 19 | MM17059 |
| Coexpression | NABA_CORE_MATRISOME | LAMB4 FRAS1 VWF MATN2 MATN3 KCP LAMA4 LAMB1 LAMB2 LAMC2 TECTA COLQ ECM1 SNED1 MFGE8 FNDC7 FBLN2 FBN2 NID1 LTBP1 FBN3 | 1.13e-17 | 275 | 152 | 21 | M5884 |
| Coexpression | NABA_MATRISOME | CLEC18A LAMB4 FRAS1 VWF CHRDL2 CLEC18B IL25 MATN2 MATN3 MUC19 KCP LAMA4 CLEC18C LAMB1 LAMB2 LAMC2 MUC5B SEMA3G TECTA GPC6 COLQ ECM1 ST14 SNED1 MFGE8 FNDC7 FBLN2 FBN2 MEGF8 CCBE1 NID1 LTBP1 MUC2 MUC5AC FBN3 | 1.25e-17 | 1026 | 152 | 35 | M5889 |
| Coexpression | NABA_MATRISOME | CLEC18A FRAS1 VWF CHRDL2 CLEC18B IL25 MATN2 MATN3 MUC19 KCP LAMA4 CLEC18C LAMB1 LAMB2 LAMC2 MUC5B SEMA3G TECTA GPC6 COLQ ECM1 ST14 SNED1 MFGE8 FNDC7 FBLN2 FBN2 MEGF8 CCBE1 NID1 LTBP1 MUC2 MUC5AC | 4.10e-16 | 1008 | 152 | 33 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | FRAS1 VWF MATN2 MATN3 KCP LAMA4 LAMB1 LAMB2 LAMC2 TECTA COLQ ECM1 SNED1 MFGE8 FNDC7 FBLN2 FBN2 NID1 LTBP1 | 1.98e-15 | 270 | 152 | 19 | MM17057 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 3.05e-09 | 40 | 152 | 7 | M5887 | |
| Coexpression | NABA_ECM_AFFILIATED | 3.76e-07 | 158 | 152 | 9 | MM17063 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 4.25e-07 | 117 | 152 | 8 | M39300 | |
| Coexpression | NABA_ECM_AFFILIATED | 6.97e-07 | 170 | 152 | 9 | M5880 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.87e-06 | 16 | 152 | 4 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.87e-06 | 16 | 152 | 4 | M2207 | |
| Coexpression | HEVNER_CORTEX_VASCULAR_ENDOTHELIAL_CELLS | 3.94e-06 | 19 | 152 | 4 | MM420 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | VWF DLL4 MATN2 LAMA4 LAMB1 LAMB2 SEMA3G ACVRL1 LDLRAD3 ECM1 NID1 NOTCH1 | 1.06e-05 | 440 | 152 | 12 | M39039 |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 1.72e-05 | 27 | 152 | 4 | M47994 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 4.95e-05 | 35 | 152 | 4 | MM17054 | |
| Coexpression | FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS | 8.84e-05 | 311 | 152 | 9 | M61 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | CLEC18A CHRDL2 CLEC18B IL25 MUC19 CLEC18C MUC5B SEMA3G GPC6 ST14 MEGF8 CCBE1 MUC2 MUC5AC | 1.06e-04 | 738 | 152 | 14 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | CLEC18A CHRDL2 CLEC18B IL25 MUC19 CLEC18C MUC5B SEMA3G GPC6 ST14 MEGF8 CCBE1 MUC2 MUC5AC | 1.27e-04 | 751 | 152 | 14 | M5885 |
| Coexpression | PDGF_UP.V1_DN | 1.46e-04 | 136 | 152 | 6 | M2832 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 1.52e-04 | 137 | 152 | 6 | M40313 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 1.52e-04 | 196 | 152 | 7 | M5381 | |
| Coexpression | GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP | 1.67e-04 | 199 | 152 | 7 | M5266 | |
| Coexpression | GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_UP | 1.67e-04 | 199 | 152 | 7 | M9269 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.72e-04 | 200 | 152 | 7 | M5930 | |
| Coexpression | GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_DN | 1.72e-04 | 200 | 152 | 7 | M3659 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 2.03e-04 | 20 | 152 | 3 | MM17053 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP | LAMB4 FRAS1 USP22 DLL4 MATN3 KCP LAMA4 LAMB1 CHD3 DLK1 SEMA3G EDN3 MFGE8 DPY19L2P2 NOTCH3 | 2.20e-04 | 891 | 152 | 15 | M45033 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 2.04e-06 | 165 | 145 | 9 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | VWF MID2 DLL4 LAMA4 LAMB1 LAMB2 SEMA3G ACVRL1 DLL1 CDC42BPB MFGE8 FBLN2 NID1 | 1.54e-05 | 456 | 145 | 13 | GSM777032_500 |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | VWF MID2 DLL4 LAMA4 LAMB1 LAMB2 SEMA3G ACVRL1 DLL1 CDC42BPB MFGE8 FBLN2 NID1 | 1.65e-05 | 459 | 145 | 13 | GSM777037_500 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | CLEC18A FRAS1 MID2 LAMA4 LAMB1 LAMC2 DLL1 FBN2 CELSR2 LRP2 LTBP1 NOTCH1 | 1.92e-05 | 398 | 145 | 12 | gudmap_kidney_P4_CapMesRenVes_Crym_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | DNAJC13 MATN2 LAMB1 DLK1 GPC6 ECM1 MAP3K1 NSD3 DMXL1 SNED1 KMT2C FBLN2 RASSF1 ZNF451 USP40 LRP1 NID1 | 3.43e-05 | 801 | 145 | 17 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#3 | 3.97e-05 | 298 | 145 | 10 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K3 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | MATN2 LAMA4 LAMB1 LAMB2 DLK1 ECM1 SNED1 FBLN2 LRP1 NID1 LTBP1 HAS1 | 4.76e-05 | 437 | 145 | 12 | GSM777046_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#2 | 5.99e-05 | 313 | 145 | 10 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K2 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_top-relative-expression-ranked_100 | 6.08e-05 | 99 | 145 | 6 | PCBC_ECTO_100 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_100 | 6.43e-05 | 100 | 145 | 6 | PCBC_ratio_ECTO_vs_SC_100 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 6.56e-05 | 62 | 145 | 5 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_200 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | ZMYND15 MATN2 LAMA4 LAMB1 LAMB2 GPC6 ECM1 SNED1 MFGE8 LRP1 NID1 NOTCH3 | 7.00e-05 | 455 | 145 | 12 | GSM777055_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.18e-04 | 275 | 145 | 9 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.38e-04 | 281 | 145 | 9 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K2 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 2.04e-04 | 175 | 145 | 7 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | MATN2 LAMA4 LAMB1 LAMB2 GPC6 ECM1 MFGE8 FBLN2 LRP1 NID1 LTBP1 | 2.47e-04 | 445 | 145 | 11 | GSM777043_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 2.94e-04 | 311 | 145 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K4 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | CLEC18A FRAS1 MID2 LAMA4 LAMB1 LAMC2 GPC6 DLL1 ST14 FBN2 CELSR2 LRP2 LTBP1 ZNF319 NOTCH1 | 3.09e-04 | 783 | 145 | 15 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | Endoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | VWF MATN3 HGSNAT CHD3 DLK1 GPC6 FBLN2 FBN2 RNF125 WTIP BAMBI LTBP1 FBN3 | 3.12e-04 | 615 | 145 | 13 | PCBC_ratio_DE_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | DNAJC13 MATN2 DLK1 GPC6 ECM1 NSD3 DMXL1 KMT2C FBLN2 FBN2 RASSF1 ZNF451 USP40 LRP1 NID1 | 3.39e-04 | 790 | 145 | 15 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | MATN2 LAMA4 LAMB1 LAMB2 GPC6 ECM1 MFGE8 LRP1 NID1 LTBP1 NOTCH3 | 3.66e-04 | 466 | 145 | 11 | GSM777050_500 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | CLEC18A CLEC18B HGSNAT CLEC18C LAMB1 LAMB2 DLK1 GPC6 DLL1 LRRC4 FAM156A FBN2 CELSR2 WTIP CCBE1 LRP2 NID1 LTBP1 SPSB3 FBN3 INO80B CRB2 | 3.96e-04 | 1466 | 145 | 22 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | VWF DGKB LAMB2 PKD2L1 SEMA3G GPC6 ECM1 FBLN2 WTIP LTBP1 NOTCH3 | 5.31e-11 | 187 | 153 | 11 | ddfc2d1d9fcc3d8e4d3d015576bb17eebf44ada9 |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-09 | 196 | 153 | 10 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-09 | 196 | 153 | 10 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | VWF USP22 DLL4 LAMA4 ACVRL1 RALGAPA2 TRIM22 KMT2C UBR5 NOTCH1 | 1.99e-09 | 200 | 153 | 10 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-09 | 160 | 153 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-09 | 160 | 153 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.90e-08 | 188 | 153 | 9 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-08 | 192 | 153 | 9 | d2c03490c5e835d0f0a732803093c64b8d4b4029 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.61e-08 | 195 | 153 | 9 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.98e-08 | 198 | 153 | 9 | 218f33e068eb126458ec33176de3cfa6fc06ddf0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-08 | 198 | 153 | 9 | 5e70246a9ce199cb2fb5379912b8ab59456219e4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.98e-08 | 198 | 153 | 9 | e1fa02184ce93c4f8aa5cf04b70949cd4c425ff0 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-08 | 198 | 153 | 9 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.11e-08 | 199 | 153 | 9 | 9c40b3ee39860e9d8edafd007daec11abdd95435 | |
| ToppCell | ASK452-Mesenchymal-Fibroblast|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.11e-08 | 199 | 153 | 9 | 4d0bf2a4bd97e5a3bfe4570a201cc21bb9c4c1f6 | |
| ToppCell | ASK452-Mesenchymal|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.11e-08 | 199 | 153 | 9 | 93e85e3731a9ece9aee3eb82c5dfdad331ee62d6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.11e-08 | 199 | 153 | 9 | 72b34bce8157abe389e95cd3ed8ba578dce0cbf6 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.11e-08 | 199 | 153 | 9 | cb3c04b91c8e8080137823b11c76ca0a2adda52d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-08 | 199 | 153 | 9 | e78f661b40da34768469549b6e755d330be6bbd8 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.25e-08 | 200 | 153 | 9 | 17ffdbc13332bd3ed1d54abcd7af20267dd4b234 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.25e-08 | 200 | 153 | 9 | 665df8391d2ebcfc6536318612f4992852b5e2b8 | |
| ToppCell | Biopsy_IPF-Mesenchymal|Biopsy_IPF / Sample group, Lineage and Cell type | 3.25e-08 | 200 | 153 | 9 | bb605b373caf3f873dc1b87d712704568e0d6040 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.25e-08 | 200 | 153 | 9 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.61e-07 | 185 | 153 | 8 | 8ed10ba581849c9c4ac4397226be2b62b4b3b900 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.61e-07 | 185 | 153 | 8 | b8052cebb73f41abe6faf0aa847be7c8ef23ae94 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.95e-07 | 188 | 153 | 8 | 0e2d1b21f0a7ee306e7dae16fc8c19d16a467883 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.20e-07 | 190 | 153 | 8 | 06bfb62b94b0faf467ef93d5bc5d08924c770098 | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-07 | 190 | 153 | 8 | 3720e64129f3f3268b1dc14031a76f41c38241c2 | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-07 | 190 | 153 | 8 | 73a50426f972f08f9bb525ad5c0b774187ab5d6a | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-07 | 190 | 153 | 8 | b55cf1fb586b724295b7b038483249847bb344fc | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-07 | 192 | 153 | 8 | 853a930e0641ffb50cbb4cef5837c70d75c3fc39 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.47e-07 | 192 | 153 | 8 | 321850b0f881420c2d57d3e825e365c82fa511ab | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-07 | 192 | 153 | 8 | 24e2f15f5767a97eb3b389922bcfd7b13805e1ce | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.47e-07 | 192 | 153 | 8 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.47e-07 | 192 | 153 | 8 | cf2765d8bc074f7f9ee864eae632a3b705175842 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-07 | 192 | 153 | 8 | 49281626ecad0456fdbded2378b7028d7b589686 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-07 | 193 | 153 | 8 | 160691b671710be10220803d788c2c961c236af1 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_progenitor_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-07 | 194 | 153 | 8 | 3d25d6ebec8d1b6001f602257cd15b3ba04cf0c1 | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-07 | 194 | 153 | 8 | 9709dc95fb6982b6a0467b507845d5bc17252e3e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.75e-07 | 194 | 153 | 8 | ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12 | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-07 | 194 | 153 | 8 | 93b7a9065430740ec31fce4e8c14ffccb498591d | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-07 | 194 | 153 | 8 | 0d2e65b44e3f143971c2fd24c4552f042b049cfa | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.75e-07 | 194 | 153 | 8 | cceb7c88492bb6cd531e1c2651638da1ddf30931 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.75e-07 | 194 | 153 | 8 | ff19fb5bc7feae3e774ef4ab720beb9dec219f45 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-07 | 195 | 153 | 8 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.90e-07 | 195 | 153 | 8 | 4658fb197657d7692ee344ae76b11b0210c418ba | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-07 | 196 | 153 | 8 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-07 | 196 | 153 | 8 | 65f2f51e17f1869f3468813127b96d3048d8ad41 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-07 | 196 | 153 | 8 | e4ed897900a6472738bc6be2fb4817192727225d | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-07 | 196 | 153 | 8 | 2cd83176f2e8a9e6fa3c08cb33928a61e5fc43b6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-07 | 196 | 153 | 8 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.21e-07 | 197 | 153 | 8 | 62c0a90869431e582bb7bb329e0b0cc59123d3d1 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.21e-07 | 197 | 153 | 8 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-07 | 197 | 153 | 8 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.21e-07 | 197 | 153 | 8 | 16f0eb047df9d702518f82ee99c6e7dc1350b2fb | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.38e-07 | 198 | 153 | 8 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.38e-07 | 198 | 153 | 8 | 72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4 | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|tumor_Lung / Location, Cell class and cell subclass | 4.38e-07 | 198 | 153 | 8 | 31f9181dab689aabe9c6182c2ef7de65ba3f0ff6 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.55e-07 | 199 | 153 | 8 | 84545ced0c792bc77980a50d65e484eab648d47e | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.55e-07 | 199 | 153 | 8 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.55e-07 | 199 | 153 | 8 | 0019cfaa586a450c2e4952d1184a540561c8d0ba | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.72e-07 | 200 | 153 | 8 | 933b5b400e48a511ba0a056be1d33d3610b5f10d | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.72e-07 | 200 | 153 | 8 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | cellseq-Mesenchymal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.72e-07 | 200 | 153 | 8 | 238285fc372ce2e5e4341fc3084a3a833bf4a0a6 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.72e-07 | 200 | 153 | 8 | 2022df85df94ab8cbb4e80e3fe9894c01051c5e0 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.72e-07 | 200 | 153 | 8 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.72e-07 | 200 | 153 | 8 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.72e-07 | 200 | 153 | 8 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.72e-07 | 200 | 153 | 8 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-intermediate_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.72e-07 | 200 | 153 | 8 | d769723f8fcb37d9b86589e0c41c1d7f16393cfe | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.72e-07 | 200 | 153 | 8 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.72e-07 | 200 | 153 | 8 | 69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.72e-07 | 200 | 153 | 8 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.72e-07 | 200 | 153 | 8 | 3a164e3971bcd62b148b813171c103adb81f972e | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.72e-07 | 200 | 153 | 8 | b04831708fa20471a127b87e8db3728b6e729ce8 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.72e-07 | 200 | 153 | 8 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.72e-07 | 200 | 153 | 8 | 6316c288022719b9e6c4332c5cb9041e1188d0e8 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.72e-07 | 200 | 153 | 8 | cbf6a6c3db88bac37bd084a3a914b12b3af524eb | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.72e-07 | 200 | 153 | 8 | 7ba292c30d915e66ebc8026fa76492cedf64700e | |
| ToppCell | Biopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.72e-07 | 200 | 153 | 8 | d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.72e-07 | 200 | 153 | 8 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.72e-07 | 200 | 153 | 8 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.72e-07 | 200 | 153 | 8 | 5a87bb8eb1c6bd2fbc357e1528e15ba1c0051438 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.07e-06 | 154 | 153 | 7 | e65e4636646164610f33f7bbac0d879a3ea55986 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.99e-06 | 169 | 153 | 7 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-06 | 170 | 153 | 7 | 55fe16d98ea284d05fb899888e4569c685644c7b | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-06 | 172 | 153 | 7 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | -Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 2.33e-06 | 173 | 153 | 7 | 88be9182fbb1bc83531cd41e59ea57c112a21d54 | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.71e-06 | 177 | 153 | 7 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.02e-06 | 180 | 153 | 7 | 64956a85c404a2ea7e4eaf6f95ebcc52c198b7cc | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.25e-06 | 182 | 153 | 7 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 3.37e-06 | 183 | 153 | 7 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.37e-06 | 183 | 153 | 7 | 8de4b616a06be03e1cb6ae6a9ce6bf06485629d3 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-06 | 184 | 153 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-06 | 184 | 153 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-06 | 184 | 153 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.50e-06 | 184 | 153 | 7 | 27cb9b5fdb157a1bd72eb0f10662bfac9359cf31 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.50e-06 | 184 | 153 | 7 | 7bc10c411c8f5b1bc64da48d6d75751086689b1d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Endothelial_Myeloid-Endo|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.50e-06 | 184 | 153 | 7 | 0fdb5d3879b5d3affc139f2c2bb250a71732869d | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|metastatic_Brain / Location, Cell class and cell subclass | 3.62e-06 | 185 | 153 | 7 | ad52970e88e8947ef256095bd4b40229b912d58a | |
| Computational | Adhesion molecules. | 2.44e-05 | 141 | 91 | 8 | MODULE_122 | |
| Drug | AC1L1G72 | 5.37e-09 | 11 | 151 | 5 | CID000003553 | |
| Drug | AC1L1B58 | 3.23e-08 | 29 | 151 | 6 | CID000001288 | |
| Drug | BM165 | 5.92e-07 | 11 | 151 | 4 | CID003352881 | |
| Drug | dysprosium | 6.09e-07 | 74 | 151 | 7 | CID000023912 | |
| Drug | I-Q-S | 1.02e-06 | 156 | 151 | 9 | CID000003540 | |
| Drug | 2,4-diaminopyrimidine | 1.53e-06 | 54 | 151 | 6 | CID000067431 | |
| Drug | kalinin | 1.71e-06 | 55 | 151 | 6 | CID000032518 | |
| Drug | LG 5 | 2.87e-06 | 60 | 151 | 6 | CID011840957 | |
| Drug | Rgd Peptide | 4.63e-06 | 239 | 151 | 10 | CID000104802 | |
| Drug | Calcort | 5.05e-06 | 38 | 151 | 5 | CID000026709 | |
| Drug | Ikvav | 5.05e-06 | 38 | 151 | 5 | CID000131343 | |
| Drug | Artemisinin [63968-64-9]; Up 200; 14.2uM; PC3; HT_HG-U133A | 6.13e-06 | 194 | 151 | 9 | 7247_UP | |
| Drug | Corticosterone [50-22-6]; Down 200; 11.6uM; PC3; HT_HG-U133A | 7.52e-06 | 199 | 151 | 9 | 4064_DN | |
| Drug | Etodolac [41340-25-4]; Up 200; 14uM; PC3; HT_HG-U133A | 7.52e-06 | 199 | 151 | 9 | 7246_UP | |
| Drug | quinaprilat | 9.43e-06 | 43 | 151 | 5 | CID000107994 | |
| Drug | AC1L9FMG | 9.82e-06 | 7 | 151 | 3 | CID000444053 | |
| Drug | ALT-711 | 1.02e-05 | 21 | 151 | 4 | CID000216304 | |
| Drug | YIGSR | 1.44e-05 | 79 | 151 | 6 | CID000123977 | |
| Drug | Sikvav | 1.78e-05 | 24 | 151 | 4 | CID005487517 | |
| Drug | Grgds | 1.91e-05 | 83 | 151 | 6 | CID000123811 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 1.91e-05 | 83 | 151 | 6 | CID011968896 | |
| Drug | 1,2-dimethylhydrazine | 2.34e-05 | 86 | 151 | 6 | CID000001322 | |
| Drug | poly-N-acetyllactosamine | 2.67e-05 | 88 | 151 | 6 | CID000119547 | |
| Drug | Urokinase | 3.32e-05 | 10 | 151 | 3 | DB00013 | |
| Drug | Econazole nitrate [24169-02-6]; Down 200; 9uM; PC3; HT_HG-U133A | 4.08e-05 | 190 | 151 | 8 | 7305_DN | |
| Drug | CC270 | 4.50e-05 | 59 | 151 | 5 | CID006918852 | |
| Drug | AC1L9INI | 4.50e-05 | 59 | 151 | 5 | CID000445839 | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 4.72e-05 | 194 | 151 | 8 | 4246_DN | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A | 4.90e-05 | 195 | 151 | 8 | 7106_UP | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 1uM; PC3; HT_HG-U133A | 5.08e-05 | 196 | 151 | 8 | 4292_DN | |
| Drug | Pepstatin A [26305-03-3]; Down 200; 5.8uM; PC3; HT_HG-U133A | 5.08e-05 | 196 | 151 | 8 | 4206_DN | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 5.08e-05 | 196 | 151 | 8 | 5438_DN | |
| Drug | Apramycin [37321-09-8]; Down 200; 7.4uM; HL60; HT_HG-U133A | 5.08e-05 | 196 | 151 | 8 | 2914_DN | |
| Drug | Clebopride maleate [84370-95-6]; Up 200; 8.2uM; PC3; HT_HG-U133A | 5.26e-05 | 197 | 151 | 8 | 6311_UP | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Up 200; 10uM; PC3; HT_HG-U133A | 5.26e-05 | 197 | 151 | 8 | 6335_UP | |
| Drug | Deptropine citrate [2169-75-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 5.46e-05 | 198 | 151 | 8 | 5543_DN | |
| Drug | Iodixanol [92339-11-2]; Up 200; 2.6uM; HL60; HT_HG-U133A | 5.46e-05 | 198 | 151 | 8 | 3023_UP | |
| Drug | Nifedipine [21829-25-4]; Down 200; 11.6uM; PC3; HT_HG-U133A | 5.46e-05 | 198 | 151 | 8 | 7303_DN | |
| Drug | Pirlindole mesylate [60762-57-4]; Down 200; 12.4uM; HL60; HT_HG-U133A | 5.65e-05 | 199 | 151 | 8 | 3140_DN | |
| Drug | Famprofazone [22881-35-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 5.86e-05 | 200 | 151 | 8 | 6029_UP | |
| Drug | Rgds Peptide | 7.61e-05 | 106 | 151 | 6 | CID000107775 | |
| Drug | Gdrgdsp | 8.89e-05 | 109 | 151 | 6 | CID000115346 | |
| Drug | chondroitin sulfate | LAMA4 LAMB1 LAMB2 LAMC2 GPC6 NT5C1B F11 FBLN2 NID1 LTBP1 HAS1 | 1.02e-04 | 413 | 151 | 11 | CID000024766 |
| Drug | B-Ms | 1.14e-04 | 114 | 151 | 6 | CID000445091 | |
| Drug | HMQC | 1.23e-04 | 15 | 151 | 3 | CID006449980 | |
| Drug | DB08434 | 1.31e-04 | 3 | 151 | 2 | CID005289220 | |
| Drug | endosulfan diol | 1.31e-04 | 3 | 151 | 2 | CID000092170 | |
| Drug | DB04780 | 1.43e-04 | 170 | 151 | 7 | CID005459389 | |
| Drug | Parthenolide [20554-84-1]; Up 200; 16.2uM; PC3; HT_HG-U133A | 1.60e-04 | 173 | 151 | 7 | 5105_UP | |
| Drug | 2-amino-5-methylpyridine | 1.62e-04 | 77 | 151 | 5 | CID000015348 | |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 2.40e-05 | 2 | 145 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | lung large cell carcinoma (biomarker_via_orthology) | 2.40e-05 | 2 | 145 | 2 | DOID:4556 (biomarker_via_orthology) | |
| Disease | cystitis (is_marker_for) | 2.40e-05 | 2 | 145 | 2 | DOID:1679 (is_marker_for) | |
| Disease | lung small cell carcinoma (biomarker_via_orthology) | 2.40e-05 | 2 | 145 | 2 | DOID:5409 (biomarker_via_orthology) | |
| Disease | triacylglycerol 58:12 measurement | 2.48e-05 | 12 | 145 | 3 | EFO_0010439 | |
| Disease | Sotos syndrome 1 (implicated_via_orthology) | 7.17e-05 | 3 | 145 | 2 | DOID:0112103 (implicated_via_orthology) | |
| Disease | sputum mucin-5B amount | 7.17e-05 | 3 | 145 | 2 | OBA_2050332 | |
| Disease | connective tissue disease (implicated_via_orthology) | 7.17e-05 | 3 | 145 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | four-jointed box protein 1 measurement | 7.17e-05 | 3 | 145 | 2 | EFO_0801605 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.36e-04 | 53 | 145 | 4 | C4707243 | |
| Disease | lung adenocarcinoma (biomarker_via_orthology) | 1.43e-04 | 4 | 145 | 2 | DOID:3910 (biomarker_via_orthology) | |
| Disease | venous thromboembolism, plasminogen activator inhibitor 1 measurement | 1.45e-04 | 21 | 145 | 3 | EFO_0004286, EFO_0004792 | |
| Disease | PR interval | 1.77e-04 | 495 | 145 | 10 | EFO_0004462 | |
| Disease | Myasthenic Syndromes, Congenital | 2.18e-04 | 24 | 145 | 3 | C0751882 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 2.38e-04 | 5 | 145 | 2 | DOID:3030 (is_marker_for) | |
| Disease | response to silica exposure, pneumoconiosis | 2.38e-04 | 5 | 145 | 2 | EFO_0005853, MONDO_0015926 | |
| Disease | response to peginterferon alfa-2a | 2.47e-04 | 25 | 145 | 3 | EFO_0010103 | |
| Disease | cholangiocarcinoma (is_marker_for) | 2.83e-04 | 64 | 145 | 4 | DOID:4947 (is_marker_for) | |
| Disease | Sezary Syndrome | 3.12e-04 | 27 | 145 | 3 | C0036920 | |
| Disease | Adams Oliver syndrome | 3.55e-04 | 6 | 145 | 2 | C0265268 | |
| Disease | laryngeal carcinoma (is_marker_for) | 3.55e-04 | 6 | 145 | 2 | DOID:2600 (is_marker_for) | |
| Disease | Distal spinal muscular atrophy | 3.55e-04 | 6 | 145 | 2 | cv:C0393541 | |
| Disease | Congenital defect of skull and scalp | 3.55e-04 | 6 | 145 | 2 | C2931779 | |
| Disease | Adams-Oliver syndrome 1 | 3.55e-04 | 6 | 145 | 2 | C4551482 | |
| Disease | 1-(1-enyl-stearoyl)-2-arachidonoyl-GPC (P-18:0/20:4) measurement | 3.55e-04 | 6 | 145 | 2 | EFO_0800394 | |
| Disease | Adams-Oliver syndrome (is_implicated_in) | 3.55e-04 | 6 | 145 | 2 | DOID:0060227 (is_implicated_in) | |
| Disease | Abdominal Aortic Aneurysm | 3.57e-04 | 68 | 145 | 4 | EFO_0004214 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 4.96e-04 | 7 | 145 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 4.96e-04 | 7 | 145 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | mean platelet volume | RAPSN VWF RSF1 PKD2L1 DLK1 PATE2 ACVRL1 CDC42BPB BTD CCBE1 TNFRSF13B NID1 LTBP1 DPY19L2P2 | 5.22e-04 | 1020 | 145 | 14 | EFO_0004584 |
| Disease | triacylglycerol 58:10 measurement | 6.22e-04 | 34 | 145 | 3 | EFO_0010437 | |
| Disease | Glioblastoma | 6.32e-04 | 79 | 145 | 4 | C0017636 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 6.34e-04 | 139 | 145 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | carbonic anhydrase-related protein 10 measurement | 6.59e-04 | 8 | 145 | 2 | EFO_0020233 | |
| Disease | Scoliosis, unspecified | 6.59e-04 | 8 | 145 | 2 | C0036439 | |
| Disease | fatty acid desaturase enzyme activity measurement | 6.59e-04 | 8 | 145 | 2 | EFO_0009791 | |
| Disease | Inflammatory Bowel Diseases | 6.78e-04 | 35 | 145 | 3 | C0021390 | |
| Disease | stomach cancer (is_marker_for) | 6.98e-04 | 142 | 145 | 5 | DOID:10534 (is_marker_for) | |
| Disease | Giant Cell Glioblastoma | 7.96e-04 | 84 | 145 | 4 | C0334588 | |
| Disease | coronary artery disease | DNAJC13 LAMB2 PKD2L1 ACVRL1 SKI NT5C1B MAP3K1 DMXL1 SCGB1D1 FBN2 CELSR2 BTD LRP1 LNX1 KDM4B | 8.19e-04 | 1194 | 145 | 15 | EFO_0001645 |
| Disease | hemangiopericytoma (is_marker_for) | 8.44e-04 | 9 | 145 | 2 | DOID:264 (is_marker_for) | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 8.44e-04 | 9 | 145 | 2 | EFO_0009824 | |
| Disease | luteinizing hormone measurement | 8.44e-04 | 9 | 145 | 2 | EFO_0007002 | |
| Disease | 1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) measurement | 1.05e-03 | 10 | 145 | 2 | EFO_0800464 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 1.10e-03 | 157 | 145 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | Squamous cell carcinoma of esophagus | 1.26e-03 | 95 | 145 | 4 | C0279626 | |
| Disease | Microphthalmos | 1.28e-03 | 11 | 145 | 2 | C0026010 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 1.28e-03 | 11 | 145 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | pulmonary fibrosis | 1.28e-03 | 11 | 145 | 2 | EFO_0009448 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.42e-03 | 45 | 145 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 1.52e-03 | 169 | 145 | 5 | DOID:3908 (is_marker_for) | |
| Disease | metabolite measurement, body weight gain | 1.53e-03 | 12 | 145 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 1.53e-03 | 12 | 145 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 1.53e-03 | 12 | 145 | 2 | C3160718 | |
| Disease | alkaline phosphatase measurement | DNAJC13 RAPSN PGAP3 MANBA KCP PKD2L1 DEFB135 CHD3 TRIM6 MFGE8 SCGB1D1 NF1 NOTCH1 | 1.54e-03 | 1015 | 145 | 13 | EFO_0004533 |
| Disease | Intellectual Disability | 1.71e-03 | 447 | 145 | 8 | C3714756 | |
| Disease | Migraine Disorders | 1.81e-03 | 13 | 145 | 2 | C0149931 | |
| Disease | level of Phosphatidylcholine (16:1_18:1) in blood serum | 1.81e-03 | 13 | 145 | 2 | OBA_2045082 | |
| Disease | birth weight, pelvic organ prolapse | 1.81e-03 | 49 | 145 | 3 | EFO_0004344, EFO_0004710 | |
| Disease | Autistic Disorder | 1.89e-03 | 261 | 145 | 6 | C0004352 | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 1.92e-03 | 50 | 145 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | Glioblastoma Multiforme | 2.23e-03 | 111 | 145 | 4 | C1621958 | |
| Disease | Proteinuria | 2.41e-03 | 15 | 145 | 2 | HP_0000093 | |
| Disease | phosphatidylcholine 38:6 measurement | 2.75e-03 | 16 | 145 | 2 | EFO_0010388 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 2.75e-03 | 16 | 145 | 2 | C0334634 | |
| Disease | adult onset asthma | 2.78e-03 | 118 | 145 | 4 | EFO_1002011 | |
| Disease | non-high density lipoprotein cholesterol measurement | DNAJC13 RAPSN NSD1 LAMC2 ZNF235 SCGB1D1 CELSR2 RASSF1 ZNHIT1 USP3 | 2.84e-03 | 713 | 145 | 10 | EFO_0005689 |
| Disease | cleft lip | 2.87e-03 | 284 | 145 | 6 | EFO_0003959 | |
| Disease | neuroimaging measurement, brain volume measurement | 2.98e-03 | 286 | 145 | 6 | EFO_0004346, EFO_0006930 | |
| Disease | Sjogren's syndrome (implicated_via_orthology) | 3.11e-03 | 17 | 145 | 2 | DOID:12894 (implicated_via_orthology) | |
| Disease | triacylglycerol 60:12 measurement | 3.11e-03 | 17 | 145 | 2 | EFO_0010444 | |
| Disease | IGF-1 measurement, IGFBP-3 measurement | 3.11e-03 | 17 | 145 | 2 | EFO_0004626, EFO_0004627 | |
| Disease | cervical artery dissection | 3.11e-03 | 17 | 145 | 2 | EFO_1000059 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 3.11e-03 | 17 | 145 | 2 | cv:C0270914 | |
| Disease | mean corpuscular hemoglobin concentration | DNAJC13 RAPSN GARS1 TMC6 DLK1 PATE2 SKI DMXL1 TRIM10 TRAF4 UBR5 CCBE1 TNFRSF13B | 3.22e-03 | 1105 | 145 | 13 | EFO_0004528 |
| Disease | syndrome (implicated_via_orthology) | 3.48e-03 | 18 | 145 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | ischemia (biomarker_via_orthology) | 3.48e-03 | 18 | 145 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 3.48e-03 | 18 | 145 | 2 | OBA_2045065 | |
| Disease | cystic fibrosis (is_marker_for) | 3.56e-03 | 62 | 145 | 3 | DOID:1485 (is_marker_for) | |
| Disease | cystatin C measurement | 3.83e-03 | 402 | 145 | 7 | EFO_0004617 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 3.88e-03 | 19 | 145 | 2 | EFO_0802076 | |
| Disease | asthma | IKZF3 RAPSN LDLRAD3 CRB1 FBLN2 LRP1 METTL25 LNX1 MUC2 MUC5AC | 4.09e-03 | 751 | 145 | 10 | MONDO_0004979 |
| Disease | Mammary Carcinoma, Human | 4.54e-03 | 525 | 145 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 4.54e-03 | 525 | 145 | 8 | C1257931 | |
| Disease | viral load | 4.62e-03 | 136 | 145 | 4 | EFO_0010125 | |
| Disease | Mammary Neoplasms | 4.65e-03 | 527 | 145 | 8 | C1458155 | |
| Disease | saturated fatty acids to total fatty acids percentage | 4.74e-03 | 21 | 145 | 2 | EFO_0022305 | |
| Disease | gastric ulcer (biomarker_via_orthology) | 4.74e-03 | 21 | 145 | 2 | DOID:10808 (biomarker_via_orthology) | |
| Disease | level of Phosphatidylcholine (16:1_18:2) in blood serum | 4.74e-03 | 21 | 145 | 2 | OBA_2045083 | |
| Disease | congenital heart disease (implicated_via_orthology) | 4.81e-03 | 69 | 145 | 3 | DOID:1682 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GARGHIYCCTRLCHQ | 36 | A8MU10 | |
| IYCCTRLCHQRAASA | 41 | A8MU10 | |
| FQGHSSCRRCLCAAE | 56 | Q96P26 | |
| LANYCHSSLHVCICI | 91 | Q4KMX7 | |
| RLECSGAISAHCNLC | 61 | A0A096LPI5 | |
| SYAVALSCQCALCRR | 131 | A6NKQ9 | |
| YCELHVSDCARNPCA | 436 | Q9NR61 | |
| LCRGRPTEFVNHYCC | 76 | P37023 | |
| ACRYCDLKELHNCTG | 1586 | Q9UKA4 | |
| TCLCRDGYTGEHCEV | 1311 | Q9HCU4 | |
| GDLAGHYTRRQCCCD | 306 | Q75N90 | |
| CDVHCINTEGSYRCS | 1166 | Q75N90 | |
| LCAFRCHNTEGSYLC | 2176 | Q75N90 | |
| GTCLQHTQVSYECLC | 221 | P80370 | |
| ASLSACIYQCLCGSH | 2236 | Q9Y485 | |
| CLCAALSSYVHACAA | 661 | Q9HC84 | |
| CSHRLCLGTCVAYGD | 886 | Q9HC84 | |
| CVRCPVAYHANDFCL | 1661 | Q96L73 | |
| VELICCDHSNYCNLP | 96 | Q6UY27 | |
| LECRVCCSLGSFYAQ | 161 | Q13702 | |
| FTCHYRCRALVCLDC | 91 | Q9NS23 | |
| NCDTCRNSACIIYSV | 406 | Q6ZSG2 | |
| SDVGDDCIRCHRAYC | 391 | Q9Y215 | |
| QCAVCHESCGSYQRL | 411 | Q5KSL6 | |
| LANYCHSSLHVCICI | 91 | P0CH98 | |
| CTANPLLCSTARYHC | 106 | Q86YD5 | |
| LLCSTARYHCKNGLC | 111 | Q86YD5 | |
| SYRCVCRATHTGPNC | 201 | P46531 | |
| CECRYCQSHRPNLSG | 126 | Q8NDB6 | |
| CAADLHNTGSICLRC | 816 | Q86XX4 | |
| EGRLLACSQCGQCYH | 971 | Q8NEZ4 | |
| TCSRVDYCLLSDHGC | 481 | O00339 | |
| CQHICVSDGAASYHC | 401 | O15232 | |
| TFQEALCLGACCHRL | 366 | Q9HB89 | |
| SCHTACTLRFELLGC | 211 | Q08431 | |
| ATCRNLADRYECHCP | 121 | Q5IJ48 | |
| HCLLGCITCGINYTV | 591 | Q5VTL7 | |
| HLCLINYNRTVSCAC | 1551 | Q07954 | |
| LCLCTSCADTLRYQA | 296 | O60291 | |
| GVCSVGCCYHLLSEE | 406 | Q8N6Q8 | |
| SYAVALSCQCALCRR | 101 | P0DN87 | |
| VCRTAQRHCCVSYLQ | 471 | P98095 | |
| CQHLCINTVGSYHCA | 616 | P98095 | |
| GACEASLACSTCHVY | 106 | Q6P4F2 | |
| AGHCINLPVRYTCIC | 886 | Q14766 | |
| HCVNTVGAFRCEYCD | 971 | Q14766 | |
| LNTCVSHICCILVFY | 236 | Q9H340 | |
| SCTQNECQTICHIYG | 1266 | Q7Z5P9 | |
| NYDILLLEHSCLCCR | 8326 | Q7Z5P9 | |
| YTHIESCQCQDTVCG | 5146 | Q02817 | |
| YCSVNNGGCTHLCLA | 1211 | P14543 | |
| TCRQSGDLTYDCACL | 211 | Q9UM47 | |
| CLNTPLSYECHCQRG | 1091 | Q7Z7M0 | |
| GKCCLQVHASCYGIR | 761 | O94953 | |
| ECGHVCSCTECYRAL | 316 | Q969V5 | |
| CGHTYCTLCLTNFLV | 56 | Q8TBB1 | |
| REYIPTNSTCCGRCH | 316 | Q9HBW1 | |
| TGHCYCKRLVTGQHC | 476 | P07942 | |
| RCLKCLYHTEGEHCQ | 996 | P07942 | |
| QIVCHCRAGYTGLRC | 951 | P55268 | |
| IDECDILGSCSQHCY | 1391 | P98164 | |
| CVCHTLAEYSRQCTH | 306 | P98088 | |
| CTHVFCFDCIQRYIL | 26 | Q6ZWI9 | |
| RQGYACEVCSFACHV | 1051 | Q9Y5S2 | |
| MYCLRCTCSEGAHVS | 56 | Q6WN34 | |
| CTCSEGAHVSCYRLH | 61 | Q6WN34 | |
| VLHCCVCGSSTYTQQ | 1301 | Q2PPJ7 | |
| RLYFLQCETCHSRCS | 296 | P20042 | |
| ACSRTGQALCSLQCY | 321 | Q9C086 | |
| ACRLASHCLAYANSC | 271 | O60755 | |
| HLRICPQEYTCCTTE | 56 | Q9Y625 | |
| CLAYVTHEDICRCFA | 136 | Q16254 | |
| GEIRCYCDAAHCVAT | 26 | Q13145 | |
| SYAVALSCQCALCRR | 101 | P0DN86 | |
| CVGRYDKACLHFCTQ | 161 | P14138 | |
| YRCHTCNTTDRNAIC | 851 | Q86XK2 | |
| AYLCRCQAGFSGRHC | 426 | O00548 | |
| NSHYELCADTCSLGC | 2736 | Q9Y6R7 | |
| HYSICTRTCQGSCAA | 5126 | Q9Y6R7 | |
| GELLCCDACISSYHI | 466 | Q12873 | |
| CAHICINTLGSYRCE | 146 | Q6UXH8 | |
| NEQYRILCDTIHLCC | 51 | Q30KP9 | |
| QGLCCSFCKYTVHER | 271 | Q9Y6T7 | |
| CQVVCTYHPRCLLFT | 46 | P03951 | |
| HVCSNGLCCYLLYER | 416 | P43251 | |
| CISHIYSLCIRTFCN | 116 | P56539 | |
| CLCLQALAIVYGRCH | 871 | O75165 | |
| CGNCTRESCVVSFYL | 761 | O00462 | |
| VERACQSYFHCVSCI | 291 | Q92839 | |
| CRCDGSVRYTHQLCL | 186 | A6NNE9 | |
| SECCYHCLFQVLVNV | 101 | Q68CP4 | |
| LCLSYVTGAHCEECT | 476 | A4D0S4 | |
| YGSALNQTCRRCSCH | 1011 | A4D0S4 | |
| GRCLKCIHNTAGIYC | 536 | Q13753 | |
| YHARCLCPHCVSLQT | 106 | Q9H293 | |
| NFLEIGYSRCCHCRS | 211 | Q16610 | |
| GLCVDLQGSYQCICH | 1906 | P35556 | |
| CLNEIGRYTCICPHN | 201 | P82279 | |
| CHLCNYACQRRDALT | 176 | Q9UKT9 | |
| ILLCDSCDSGYHTAC | 906 | Q96T23 | |
| ATNVYLRCCLCRCHA | 331 | Q6ZN68 | |
| LNEHIVCCLCAGYFV | 41 | Q9BSM1 | |
| NCTQECLIYGHSDAC | 1131 | Q9BZA8 | |
| CLDGSGYCVHCQRNT | 91 | Q16363 | |
| CASTVILHSIYLCCV | 171 | Q96FM1 | |
| CSFHLTVVLLQYGCC | 246 | Q8NGQ4 | |
| NCSCARGTFCIHLLF | 346 | Q13233 | |
| LTCEREGCQTEFCYH | 226 | Q6ZMZ0 | |
| RHVICLDCFHLYCVT | 256 | O60260 | |
| ACLCDALEAYASHCR | 1451 | Q6ZWJ8 | |
| SCCYFCGTVCSLIHL | 146 | Q8NGL2 | |
| SCSYICQHCLVHLGD | 146 | Q92540 | |
| CADRSCYDLSCHARA | 461 | P41250 | |
| HICRTVICNCTTYDG | 391 | Q8WXH5 | |
| RTDCIICCSAYDLSG | 21 | P0DH78 | |
| LYCGHTFCQACVRRL | 41 | P0DH78 | |
| NVCGNLCTDCDRFLH | 4276 | O75592 | |
| SHSSTEACCELCGLY | 1391 | O95785 | |
| CASATSLQYLCCHRL | 271 | Q6PJ21 | |
| AVCDELHIYCSRCTA | 141 | P12755 | |
| LCLCSTGYEGAHCEL | 776 | Q8TER0 | |
| TLALCCYRANAVVCQ | 11 | O95968 | |
| TGRYCQVRCSLQCVH | 256 | A5D8T8 | |
| TGRYCQVRCSLQCVH | 256 | Q6UXF7 | |
| TGRYCQVRCSLQCVH | 256 | Q8NCF0 | |
| CYCSGTDNRVHCETI | 1061 | O75443 | |
| RTSCFSLTNCGHVYC | 16 | Q495C1 | |
| SLTNCGHVYCDACLG | 21 | Q495C1 | |
| TSNQLTCGCRESYIC | 716 | Q9Y4E5 | |
| SSYQCRECGLCYTSH | 1201 | Q9HCE3 | |
| TDQDCLGERKCCYLH | 51 | Q8WWY7 | |
| CGVHLNRLHSCLYCV | 66 | Q9UPT9 | |
| HLSCEFRECGYCNIN | 101 | Q96MF0 | |
| AGNYTVCQKDLCCHL | 351 | O95497 | |
| GCRRCHATFSCVFEL | 1671 | Q9C0A1 | |
| RCGHVFCRSCIATSL | 51 | Q96EQ8 | |
| VIASYAHLCRTNGVC | 2176 | P04275 | |
| FTYVLHEGECCGRCL | 2481 | P04275 | |
| SCLHSVCEQCLQILY | 161 | Q9H0X6 | |
| QFCQLCSRRYCLSHH | 911 | P38935 | |
| STECGHVFCSQCLRD | 151 | P78317 | |
| TCTKHTYRCLNGLCL | 566 | Q9Y5Y6 | |
| LRSVCHCLYQATCHS | 1361 | P21359 | |
| VSTCGHRFCDTCLQE | 31 | Q9BUZ4 | |
| YCEQDRALVCGVCAS | 96 | Q6ZMU5 | |
| AYRTQVSSCCLHICQ | 61 | Q9P0L9 | |
| CYTCGRLGHLARDCD | 91 | Q8WW36 | |
| YNLDCLGNGRTECHC | 1261 | Q9BZ95 | |
| RDGIHCLQCNSSLVY | 331 | Q9BS86 | |
| YCSHCRSEVRGTQCA | 901 | Q6PJI9 | |
| CCRLCLQHLQIFTYE | 146 | Q86UK7 | |
| HLLRDCISCASICGQ | 81 | O14836 | |
| CLTCSSVHCGRYVNG | 41 | Q9Y6I4 | |
| CLAGHDRSFQCTQCL | 96 | Q9P2F9 | |
| SRLCCTCEAAYRVLH | 161 | Q5T4F4 | |
| CGHNFCRACLTRYCE | 31 | Q9UDY6 | |
| QLRLHQCETYGTACA | 516 | Q9NS98 | |
| YHTDCFTCDSCGRRL | 246 | A6NIX2 | |
| CCGRLRYACVLALHS | 201 | Q7Z403 | |
| CGARYCTVRCLGTHQ | 131 | O43257 | |
| TCEVSYCDRCLRATH | 156 | Q9UJV3 | |
| LSLDCGHSFCQACIT | 26 | Q8IYM9 | |
| VFDCDNLYHCGTCDR | 211 | Q9NVE5 | |
| YICDVCCKGFSQRSH | 711 | Q14590 | |
| CSAVLYCGEACLRAD | 331 | Q9H091 | |
| CLSCSHVACGRYIEE | 41 | Q9H0E7 | |
| LSIDCGHSFCQACIT | 26 | Q9C030 | |
| CLHTYCQDCLAQLAD | 36 | Q9BRZ2 | |
| ERIVSLHCCALYTCA | 471 | O95071 | |
| LHCCALYTCAQLENS | 476 | O95071 | |
| EGHLLACSQCSQCYH | 1391 | O14686 |